FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ele Ferrannini

Research Profile

Chemicals & Drugs

Disorders

Devices

Glucose Clamp Technique

Procedures

Glucose Tolerance Test

Anatomy

Activities & Behaviors

Fasting

Concepts & Ideas

Risk Factors

Co-author Network

Publications

TOP 3
Michaela Kozakova; Markku Laakso; Andrea Natali; Peter Nilsson; Beverley Balkau; Henning Beck-Nielsen; Jacqueline Dekker; Ele Ferrannini
Insulin sensitivity and carotid intima-media thickness: relationship between insulin sensitivity and cardiovascular risk study.
Simona Baldi; Silvia Frascerra; Maurizio Innocenti; Alberto Lippi; Monica Nannipieri; Paolo Rindi; Ele Ferrannini
Effects of hemodialysis and vitamin E supplementation on low-density lipoprotein oxidizability in end-stage renal failure.
Andrea Natali; R Ribeiro; M Rossi; A Tulipani; E Venturi; S Baldi; M P Macedo; Andrea Mari; Ele Ferrannini
Systemic inhibition of nitric oxide synthesis in non-diabetic individuals produces a significant deterioration in glucose tolerance by increasing insulin clearance and inhibiting insulin secretion.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ele Ferrannini (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Michaela Kozakova; Markku Laakso; Andrea Natali; Peter Nilsson; Beverley Balkau; Henning Beck-Nielsen; Jacqueline Dekker; Ele Ferrannini
Insulin sensitivity and carotid intima-media thickness: relationship between insulin sensitivity and cardiovascular risk study.
Arteriosclerosis, thrombosis, and vascular biology 2013;33(6):1409-17.
2013: Simona Baldi; Silvia Frascerra; Maurizio Innocenti; Alberto Lippi; Monica Nannipieri; Paolo Rindi; Ele Ferrannini
Effects of hemodialysis and vitamin E supplementation on low-density lipoprotein oxidizability in end-stage renal failure.
Journal of nephrology 2013;26(3):549-55.
2013: Andrea Natali; R Ribeiro; M Rossi; A Tulipani; E Venturi; S Baldi; M P Macedo; Andrea Mari; Ele Ferrannini
Systemic inhibition of nitric oxide synthesis in non-diabetic individuals produces a significant deterioration in glucose tolerance by increasing insulin clearance and inhibiting insulin secretion.
Diabetologia 2013;56(5):1183-91.
2013: Ele Ferrannini; Ronald A Smulders; Stephan A Veltkamp; Takeshi Kadokura
Renal Glucose Handling: Impact of chronic kidney disease and sodium-glucose cotransporter 2 inhibition in patients with type 2 diabetes.
Diabetes care 2013;36(5):1260-5.
2013: Vivian A Fonseca; Greg Ball; Perminder Dhanjal; Ele Ferrannini; John P Wilding; Wim Wilpshaar; Sally Klasen
Active- and placebo-controlled dose-finding study to assess the efficacy, safety, and tolerability of multiple doses of ipragliflozin in patients with type 2 diabetes mellitus.
Journal of diabetes and its complications 2013;27(3):268-73.
2013: Ele Ferrannini; Klaus-Peter Adam; Jerzy Adamski; Stefania Camastra; Leif Groop; Gabi Kastenmüller; Valeriya Lyssenko; Andrea Mari; Michael V Milburn; Monica Nannipieri; Andrea Natali; Tiinamaija Tuomi; Walter E Gall
Early metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significance.
Diabetes 2013;62(5):1730-7.
2013: Alessandro Antonelli; Marco Centanni; Ele Ferrannini; Silvia Martina Ferrari; Clodoveo Ferri; Caterina Mancusi; Valeria Mazzi; C Pupilli; Poupak Fallahi
Interferon-α, -β and -γ induce CXCL11 secretion in human thyrocytes: modulation by peroxisome proliferator-activated receptor γ agonists.
Immunobiology 2013;218(5):690-5.
2013: Andrea Cossu; Poupak Fallahi; Ele Ferrannini; Alessandro Antonelli; Leonardo A Sechi
Antibodies recognizing specific Mycobacterium avium subsp. paratuberculosis's MAP3738c protein in type 1 diabetes mellitus children are associated with serum Th1 (CXCL10) chemokine.
Cytokine 2013;61(2):337-9.
2013: Jeff Cobb; Klaus-Peter Adam; Eric Button; Walter Gall; James Hathorn; Kay Lawton; Michael Milburn; Matthew Mitchell; Pamela Nakhle; Andrea Natali; Regis Perichon; Ele Ferrannini
A novel fasting blood test for insulin resistance and prediabetes.
Journal of diabetes science and technology 2013;7(1):100-10.
2013: M Seghieri; Brenno Astiarraga; E Barsotti; Arturo Casolaro; Amalia Gastaldelli; Elza Muscelli; M Nauck; Alessandro Pocai; E Rebelos; Ele Ferrannini
Direct effect of GLP-1 infusion on endogenous glucose production in humans.
Diabetologia 2013;56(1):156-61.
2012: Wolfram Doehner; John A Dormandy; Erland Erdmann; Ele Ferrannini; Richard Cairns; Andrew L Clark; Stefan D Anker
Inverse relation of body weight and weight change with mortality and morbidity in patients with type 2 diabetes and cardiovascular co-morbidity: an analysis of the PROactive study population.
International journal of cardiology 2012;162(1):20-6.
2012: Alessandro Antonelli; Alda Corrado; Poupak Fallahi; Ele Ferrannini; Silvia Martina Ferrari; Silvia Frascerra; Andreina Manfredi; Mario Miccoli; Marco Sebastiani; Anna Linda Zignego; Clodoveo Ferri
Chemokine (CXC motif) ligand 9 serum levels in mixed cryoglobulinaemia are associated with circulating levels of IFN-gamma and TNF-alpha.
Clinical and experimental rheumatology 2012;30(6):864-70.
2012: S Masi; Maria-Aurora Morales; Danilo Neglia; Pirjo Nuutila; S Pardini; C Porciello; Piero A Salvadori; A M Sironi; V Chubuchny; Pietro Di Cecco; M Emdin; Ele Ferrannini; Letizia Guiducci; Juhani Knuuti; Riikka Lautamäki; Patricia Iozzo
Similar patterns of myocardial metabolism and perfusion in patients with type 2 diabetes and heart disease of ischaemic and non-ischaemic origin.
Diabetologia 2012;55(9):2494-500.
2012: Ele Ferrannini; William C Cushman
Diabetes and hypertension: the bad companions.
Lancet 2012;380(9841):601-10.
2012: Elza Muscelli; Giuseppe Seghieri; Amalia Gastaldelli; Jens Holst; Andrea Mari; Maria Alba; Brenno Astiarraga; Arturo Casolaro; Yu Chen; Ele Ferrannini
Mechanisms for the antihyperglycemic effect of sitagliptin in patients with type 2 diabetes.
The Journal of clinical endocrinology and metabolism 2012;97(8):2818-26.
2012: Alessandro Antonelli; Fulvio Basolo; Andrea Di Domenicantonio; Poupak Fallahi; Ele Ferrannini; Silvia Martina Ferrari; David Galleri; Simona Piaggi; Libero Santarpia; Paolo Miccoli
Variable modulation by cytokines and thiazolidinediones of the prototype Th1 chemokine CXCL10 in anaplastic thyroid cancer.
Cytokine 2012;59(2):218-22.
2012: Ele Ferrannini; Anna Solini
SGLT2 inhibition in diabetes mellitus: rationale and clinical prospects.
Nature reviews. Endocrinology 2012;8(8):495-502.
2012: Patricia Iozzo; H Laine; Ele Ferrannini; M A Guzzardi; M J Honka; Antti Viljanen; Pirjo Nuutila
The interaction of blood flow, insulin, and bradykinin in regulating glucose uptake in lower-body adipose tissue in lean and obese subjects.
The Journal of clinical endocrinology and metabolism 2012;97(7):E1192-6.
2012: S E Inzucchi; R M Bergenstal; J B Buse; M Diamant; Ele Ferrannini; M Nauck; A L Peters; A Tsapas; R Wender; D R Matthews
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
Diabetologia 2012;55(6):1577-96.
2012: Silvio E Inzucchi; David R Matthews; Michael Nauck; Anne L Peters; Apostolos Tsapas; Richard Wender; Richard M Bergenstal; John B Buse; Michaela Diamant; Ele Ferrannini
Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
Diabetes care 2012;35(6):1364-79.
2012: Andrea Natali; Ele Ferrannini
Endothelial dysfunction in type 2 diabetes.
Diabetologia 2012;55(6):1559-63.
2012: Tomoaki Shimizu; John B Buse; Mayer B Davidson; Ele Ferrannini; Rury R Holman; David M Nathan; Robert Sherwin; Bernard Zinman
[Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes].
Nihon rinsho. Japanese journal of clinical medicine 2012;70 Suppl 3():591-601.
2012: Alessandro Antonelli; Giampaolo Bernini; Ele Ferrannini; Silvia Martina Ferrari; Silvia Frascerra; Stefania Gelmini; C Pupilli; Ilaria Ruffilli; Stefano Sellari-Franceschini; Poupak Fallahi
β (CCL2) and α (CXCL10) chemokine modulations by cytokines and peroxisome proliferator-activated receptor-α agonists in Graves' ophthalmopathy.
The Journal of endocrinology 2012;213(2):183-91.
2012: Michaela Kozakova; Asimina Mitrakou; Carlo Palombo; Marco Paterni Eng; Jacqueline Dekker; Ele Ferrannini; Allan Flyvbjerg; Amalia Gastaldelli
Fatty liver index, gamma-glutamyltransferase, and early carotid plaques.
Hepatology (Baltimore, Md.) 2012;55(5):1406-15.
2012: Anna Maria Sironi; Massimo Lombardi; R Petz; Positano Vincenzo; Emma Buzzigoli; Demetrio Ciociaro; Daniele De Marchi; Ele Ferrannini; Amalia Gastaldelli
Impact of increased visceral and cardiac fat on cardiometabolic risk and disease.
Diabetic medicine : a journal of the British Diabetic Association 2012;29(5):622-7.
2012: Alessandro Antonelli; M Centanni; Poupak Fallahi; Sergio Ferrari; L Ghiadoni; C Mancusi; S Taddei; A Virdis; Ele Ferrannini
High serum levels of CXC (CXCL10) and CC (CCL2) chemokines in untreated essential hypertension.
International journal of immunopathology and pharmacology 2012;25(2):387-95.
2012: Ele Ferrannini
Physiology of glucose homeostasis and insulin therapy in type 1 and type 2 diabetes.
Endocrinology and metabolism clinics of North America 2012;41(1):25-39.
2012: Andrea Tura; Giovanni Pacini; Ralph DeFronzo; Ele Ferrannini; Amalia Gastaldelli; Alexandra Kautzky-Willer; Andrea Mari
Estimation of prehepatic insulin secretion: comparison between standardized C-peptide and insulin kinetic models.
Metabolism: clinical and experimental 2012;61(3):434-43.
2011: Stephanie Madec; Chiara Rossi; Antonio Salvati; Eleonora Santini; Massimo Chiarugi; Ele Ferrannini; Anna Solini
Adipocyte P2X7 receptors expression: a role in modulating inflammatory response in subjects with metabolic syndrome?
Atherosclerosis 2011;219(2):552-8.
2011: Anna Solini; Stephanie Madec; Chiara Rossi; Antonio Salvati; Eleonora Santini; Ele Ferrannini
Angiotensin-II and rosuvastatin influence matrix remodeling in human mesangial cells via metalloproteinase modulation.
Journal of hypertension 2011;29(10):1930-9.
2011: Cecilia Morgantini; Andrea Natali; Mohamad Navab; Beatrice Boldrini; Ele Ferrannini; Alan M Fogelman; Satoshi Imaizumi; Srinivasa T Reddy
Anti-inflammatory and antioxidant properties of HDLs are impaired in type 2 diabetes.
Diabetes 2011;60(10):2617-23.
2011: M Fernandez; Ele Ferrannini; Amalia Gastaldelli; Jean Hardies; Nicolas Musi; R Petz; Puntip Tantiwong; Curtis Triplitt; A Casolaro; Eugenio Cersosimo; Ralph DeFronzo
Metabolic effects of muraglitazar in type 2 diabetic subjects.
Diabetes, obesity & metabolism 2011;13(10):893-902.
2011: Monica Nannipieri; D Guarino; Andrea Mari; M Anselmino; S Baldi; E Barsotti; R Bellini; R D Berta; Stefania Camastra; Ele Ferrannini
The role of beta-cell function and insulin sensitivity in the remission of type 2 diabetes after gastric bypass surgery.
The Journal of clinical endocrinology and metabolism 2011;96(9):E1372-9.
2011: Stefania Camastra; Marco Anselmino; S Baldi; S Bonuccelli; Silvia Frascerra; A Gastaldelli; Andrea Mari; Elza Muscelli; Monica Nannipieri; E Rebelos; Giovanna Scartabelli; Ele Ferrannini
Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes.
Diabetologia 2011;54(8):2093-102.
2011: Alessandro Antonelli; Salvatore Benvenga; Alda Corrado; Ele Ferrannini; Silvia Martina Ferrari; Ferdinando Franzoni; Silvia Frascerra; Fabio Galetta; Mario Miccoli; Aldo Paolicchi; Poupak Fallahi
Circulating chemokine (CXC motif) ligand (CXCL)9 is increased in aggressive chronic autoimmune thyroiditis, in association with CXCL10.
Cytokine 2011;55(2):288-93.
2011: Aureo Ludovico De Paula; Carolina C L DePaula; Alfredo Halpern; Andrea Mari; Elza Muscelli; alessandro Stival; sergio Vencio; Ele Ferrannini
Improvement in insulin sensitivity and β-cell function following ileal interposition with sleeve gastrectomy in type 2 diabetic patients: potential mechanisms.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2011;15(8):1344-53.
2011: Ele Ferrannini; R Spanheimer; R G Wilcox; D J Betteridge; B Charbonnel; Ralph DeFronzo; J A Dormandy; E Erdmann; M Laakso
High-density lipoprotein-cholesterol and not HbA1c was directly related to cardiovascular outcome in PROactive.
Diabetes, obesity & metabolism 2011;13(8):759-64.
2011: Stephanie Madec; Eleonora Santini; Valentina Corretti; Ele Ferrannini; Anna Solini
Effect of a fatty meal on inflammatory markers in healthy volunteers with a family history of type 2 diabetes.
The British journal of nutrition 2011;106(3):364-8.
2011: Eleni Rebelos; Beverley Balkau; Ele Ferrannini; Thomas Konrad; Andrea Mari; Geltrude Mingrone; Elza Muscelli; Andrea Natali; PierMarco Piatti
Body weight, not insulin sensitivity or secretion, may predict spontaneous weight changes in nondiabetic and prediabetic subjects: the RISC study.
Diabetes 2011;60(7):1938-45.
2011: Alessandro Antonelli; Silvia Martina Ferrari; Silvia Frascerra; Alda Corrado; C Pupilli; Giampaolo Bernini; Salvatore Benvenga; Ele Ferrannini; Poupak Fallahi
Peroxisome proliferator-activated receptor α agonists modulate Th1 and Th2 chemokine secretion in normal thyrocytes and Graves' disease.
Experimental cell research 2011;317(11):1527-33.
2011: Robert H Eckel; Steven E Kahn; Ele Ferrannini; Allison B Goldfine; David M Nathan; Michael W Schwartz; Robert J Smith; Steven R Smith
Obesity and type 2 diabetes: what can be unified and what needs to be individualized?
The Journal of clinical endocrinology and metabolism 2011;96(6):1654-63.
2011: Robert H Eckel; Steven E Kahn; Ele Ferrannini; Allison B Goldfine; David M Nathan; Michael W Schwartz; Robert J Smith; Steven R Smith
Obesity and type 2 diabetes: what can be unified and what needs to be individualized?
Diabetes care 2011;34(6):1424-30.
2011: Alessandro Antonelli; Silvia Martina Ferrari; Silvia Frascerra; Andrea Di Domenicantonio; Andrea Nicolini; Paola Ferrari; Ele Ferrannini; Poupak Fallahi
Increase of circulating CXCL9 and CXCL11 associated with euthyroid or subclinically hypothyroid autoimmune thyroiditis.
The Journal of clinical endocrinology and metabolism 2011;96(6):1859-63.
2011: Ele Ferrannini; A Golay; M Laakso; Andrea Mari; Elza Muscelli; Andrea Natali; P M Nilsson; H Beck-Nielsen
Natural history and physiological determinants of changes in glucose tolerance in a non-diabetic population: the RISC Study.
Diabetologia 2011;54(6):1507-16.
2011: Anna Solini; Ele Ferrannini
Pathophysiology, prevention and management of chronic kidney disease in the hypertensive patient with diabetes mellitus.
Journal of clinical hypertension (Greenwich, Conn.) 2011;13(4):252-7.
2011: Ele Ferrannini
Learning from glycosuria.
Diabetes 2011;60(3):695-6.
2011: Ele Ferrannini; Amalia Gastaldelli; Patricia Iozzo
Pathophysiology of prediabetes.
The Medical clinics of North America 2011;95(2):327-39, vii-viii.
2011: Stefania Camastra; Chiara Chiellini; Roberta Petz; Amalia Gastaldelli; Ele Ferrannini
[Bariatric surgery as a treatment of type 2 diabetes].
Recenti progressi in medicina 2011;102(2):82-7.
2011: Alessandro Antonelli; Silvia Martina Ferrari; Poupak Fallahi; Simona Piaggi; Aldo Paolicchi; Stefano Sellari Franceschini; Mario Salvi; Ele Ferrannini
Cytokines (interferon-γ and tumor necrosis factor-α)-induced nuclear factor-κB activation and chemokine (C-X-C motif) ligand 10 release in Graves disease and ophthalmopathy are modulated by pioglitazone.
Metabolism: clinical and experimental 2011;60(2):277-83.
2011: Marco Rossi; Monica Nannipieri; Marco Anselmino; Margherita Pesce; Elza Muscelli; Gino Santoro; Ele Ferrannini
Skin vasodilator function and vasomotion in patients with morbid obesity: effects of gastric bypass surgery.
Obesity surgery 2011;21(1):87-94.
2010: Alessandro Antonelli; Silvia Martina Ferrari; Silvia Frascerra; Cinzia Pupilli; Caterina Mancusi; Maria Rita Metelli; Claudio Orlando; Ele Ferrannini; Poupak Fallahi
CXCL9 and CXCL11 chemokines modulation by peroxisome proliferator-activated receptor-alpha agonists secretion in Graves' and normal thyrocytes.
The Journal of clinical endocrinology and metabolism 2010;95(12):E413-20.
2010: Andrea Natali; Elza Muscelli; Andrea Mari; Beverley Balkau; Mark Walker; Andrea Tura; Christian Anderwald; Alain Golay; Ele Ferrannini
Insulin sensitivity and beta-cell function in the offspring of type 2 diabetic patients: impact of line of inheritance.
The Journal of clinical endocrinology and metabolism 2010;95(10):4703-11.
2010: Ele Ferrannini; Silvia Jimenez Ramos; Afshin Salsali; Weihua Tang; James F List
Dapagliflozin monotherapy in type 2 diabetic patients with inadequate glycemic control by diet and exercise: a randomized, double-blind, placebo-controlled, phase 3 trial.
Diabetes care 2010;33(10):2217-24.
2010: Patricia Iozzo; Marco Bucci; Anne Roivainen; Kjell Någren; Mikko J Järvisalo; Jan Kiss; Letizia Guiducci; Barbara Fielding; Alexandru Naum; Ronald Borra; Kirsi Virtanen; Timo Savunen; Piero A Salvadori; Ele Ferrannini; Juhani Knuuti; Pirjo Nuutila
Fatty acid metabolism in the liver, measured by positron emission tomography, is increased in obese individuals.
Gastroenterology 2010;139(3):846-56, 856.e1-6.
2010: Stephanie Madec; Massimo Chiarugi; Eleonora Santini; Chiara Rossi; Paolo Miccoli; Ele Ferrannini; Anna Solini
Pattern of expression of inflammatory markers in adipose tissue of untreated hypertensive patients.
Journal of hypertension 2010;28(7):1459-65.
2010: Ele Ferrannini
Sodium-glucose transporter-2 inhibition as an antidiabetic therapy.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2010;25(7):2041-3.
2010: Stefano Di Marco; Beatrice Boldrini; Umberto Conti; Gabriella Marcucci; Cecilia Morgantini; Ele Ferrannini; Andrea Natali
Effects of GIK (glucose-insulin-potassium) on stress-induced myocardial ischaemia.
Clinical science (London, England : 1979) 2010;119(1):37-44.
2010: Alessandro Antonelli; Silvia Martina Ferrari; Poupak Fallahi; Emiliano Ghiri; Clara Crescioli; Paola Romagnani; Paolo Vitti; Mario Serio; Ele Ferrannini
Interferon-alpha, -beta and -gamma induce CXCL9 and CXCL10 secretion by human thyrocytes: modulation by peroxisome proliferator-activated receptor-gamma agonists.
Cytokine 2010;50(3):260-7.
2010: Ele Ferrannini
The stunned beta cell: a brief history.
Cell metabolism 2010;11(5):349-52.
2010: Alessandro Antonelli; Clodoveo Ferri; Silvia Martina Ferrari; Santino Marchi; Nicola De Bortoli; Domenico Sansonno; Chiara Chiavacci; Ele Ferrannini; Poupak Fallahi
N-terminal pro-brain natriuretic peptide and tumor necrosis factor-alpha both are increased in patients with Hepatitis C.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2010;30(5):359-63.
2010: Bo Ahrén; James E Foley; Ele Ferrannini; David R Matthews; Bernard Zinman; Sylvie Dejager; Vivian A Fonseca
Changes in prandial glucagon levels after a 2-year treatment with vildagliptin or glimepiride in patients with type 2 diabetes inadequately controlled with metformin monotherapy.
Diabetes care 2010;33(4):730-2.
2010: Ele Ferrannini; Andrea Mari; Valentina Nofrate; Jay M Sosenko; Jay S Skyler
Progression to diabetes in relatives of type 1 diabetic patients: mechanisms and mode of onset.
Diabetes 2010;59(3):679-85.
2010: Walter E Gall; Kirk Beebe; Kay A Lawton; Klaus-Peter Adam; Matthew W Mitchell; Pamela J Nakhle; John A Ryals; Michael V Milburn; Monica Nannipieri; Stefania Camastra; Andrea Natali; Ele Ferrannini
alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population.
PloS one 2010;5(5):e10883.
2009: Andrea Natali; Elza Muscelli; Arturo Casolaro; Peter Nilsson; Ole Melander; Nebojsa Lalic; Ele Ferrannini; John R Petrie
Metabolic characteristics of prehypertension: role of classification criteria and gender.
Journal of hypertension 2009;27(12):2394-402.
2009: Anna Solini; Eleonora Santini; Angelina Passaro; S Madec; Ele Ferrannini
Family history of hypertension, anthropometric parameters and markers of early atherosclerosis in young healthy individuals.
Journal of human hypertension 2009;23(12):801-7.
2009: Monica Nannipieri; F Cecchetti; Marco Anselmino; Stefania Camastra; P Niccolini; M Lamacchia; marco rossi; Giorgio Iervasi; Ele Ferrannini
Expression of thyrotropin and thyroid hormone receptors in adipose tissue of patients with morbid obesity and/or type 2 diabetes: effects of weight loss.
International journal of obesity (2005) 2009;33(9):1001-6.
2009: Ester Vanni; Maria Lorena Abate; Elena Gentilcore; Ingrid Hickman; Roberto Gambino; Maurizio Cassader; Antonina Smedile; Ele Ferrannini; Mario Rizzetto; Giulio Marchesini; Amalia Gastaldelli; Elisabetta Bugianesi
Sites and mechanisms of insulin resistance in nonobese, nondiabetic patients with chronic hepatitis C.
Hepatology (Baltimore, Md.) 2009;50(3):697-706.
2009: Sandra Bonuccelli; Elza Muscelli; Amalia Gastaldelli; Elisabetta Barsotti; Brenno Astiarraga; Jens J Holst; Andrea Mari; Ele Ferrannini
Improved tolerance to sequential glucose loading (Staub-Traugott effect): size and mechanisms.
American journal of physiology. Endocrinology and metabolism 2009;297(2):E532-7.
2009: Robert Spanheimer; D John Betteridge; Meng Tan; Ele Ferrannini; Bernard Charbonnel
Long-term lipid effects of pioglitazone by baseline anti-hyperglycemia medication therapy and statin use from the PROactive experience (PROactive 14).
The American journal of cardiology 2009;104(2):234-9.
2009: Vivian Fonseca; Silvio E Inzucchi; Ele Ferrannini
Redefining the diagnosis of diabetes using glycated hemoglobin.
Diabetes care 2009;32(7):1344-5.
2009: Amalia Gastaldelli; Arturo Casolaro; Demetrio Ciociaro; Silvia Frascerra; Monica Nannipieri; Emma Buzzigoli; Ele Ferrannini
Decreased whole body lipolysis as a mechanism of the lipid-lowering effect of pioglitazone in type 2 diabetic patients.
American journal of physiology. Endocrinology and metabolism 2009;297(1):E225-30.
2009: Ele Ferrannini
Insulin resistance versus beta-cell dysfunction in the pathogenesis of type 2 diabetes.
Current diabetes reports 2009;9(3):188-9.
2009: Alessandro Antonelli; Clodoveo Ferri; Poupak Fallahi; Silvia Martina Ferrari; Silvia Frascerra; Alessandro Pampana; Erica Panicucci; Angelo Carpi; Andrea Nicolini; Ele Ferrannini
CXCL10 and CCL2 chemokine serum levels in patients with hepatitis C associated with autoimmune thyroiditis.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2009;29(6):345-51.
2009: Eleonora Santini; Sabina Cuccato; Stephanie Madec; Daniele Chimenti; Ele Ferrannini; Anna Solini
Extracellular adenosine 5'-triphosphate modulates insulin secretion via functionally active purinergic receptors of X and Y subtype.
Endocrinology 2009;150(6):2596-602.
2009: Alessandro Antonelli; Silvia Martina Ferrari; Poupak Fallahi; Piero Berti; Gabriele Materazzi; Michele Minuto; Riccardo Giannini; Ivo Marchetti; Lucio Barani; Fulvio Basolo; Ele Ferrannini; Paolo Miccoli
Thiazolidinediones and antiblastics in primary human anaplastic thyroid cancer cells.
Clinical endocrinology 2009;70(6):946-53.
2009: Alessandro Antonelli; Silvia Martina Ferrari; Poupak Fallahi; Silvia Frascerra; Eleonora Santini; Stefano Sellari Franceschini; Ele Ferrannini
Monokine induced by interferon gamma (IFNgamma) (CXCL9) and IFNgamma inducible T-cell alpha-chemoattractant (CXCL11) involvement in Graves' disease and ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists.
The Journal of clinical endocrinology and metabolism 2009;94(5):1803-9.
2009: Ele Ferrannini; Marco Massari; Monica Nannipieri; Andrea Natali; R Lopez Ridaura; C Gonzales-Villalpando
Plasma glucose levels as predictors of diabetes: the Mexico City diabetes study.
Diabetologia 2009;52(5):818-24.
2009: Monica Nannipieri; F Cecchetti; Marco Anselmino; E Mancini; G Marchetti; Alessandra Bonotti; Simona Baldi; B Solito; Monica Giannetti; Aldo Pinchera; Ferruccio Santini; Ele Ferrannini
Pattern of expression of adiponectin receptors in human liver and its relation to nonalcoholic steatohepatitis.
Obesity surgery 2009;19(4):467-74.
2009: Ele Ferrannini; Geltrude Mingrone
Impact of different bariatric surgical procedures on insulin action and beta-cell function in type 2 diabetes.
Diabetes care 2009;32(3):514-20.
2009: Ele Ferrannini; V Fonseca; B Zinman; D Matthews; B Ahrén; S Byiers; Q Shao; S Dejager
Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy.
Diabetes, obesity & metabolism 2009;11(2):157-66.
2009: Alessandro Antonelli; Poupak Fallahi; Andrea Delle Sedie; Silvia Martina Ferrari; Marco Maccheroni; Stefano Bombardieri; Lucrezia Riente; Ele Ferrannini
High values of Th1 (CXCL10) and Th2 (CCL2) chemokines in patients with psoriatic arthtritis.
Clinical and experimental rheumatology 2009;27(1):22-7.
2009: Stefania Camastra; Melania Manco; Silvia Frascerra; A Iaconelli; Geltrude Mingrone; Ele Ferrannini
Daylong pituitary hormones in morbid obesity: effects of bariatric surgery.
International journal of obesity (2005) 2009;33(1):166-72.
2009: David M Nathan; John B Buse; Mayer B Davidson; Ele Ferrannini; Rury R Holman; Robert S Sherwin; Bernard Zinman
Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes.
Diabetes care 2009;32(1):193-203.
2009: David M Nathan; John B Buse; Mayer B Davidson; Ele Ferrannini; Rury R Holman; Robert S Sherwin; B Zinman
Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.
Diabetologia 2009;52(1):17-30.
2009: Alessandro Antonelli; Piera Fazzi; Poupak Fallahi; Silvia Martina Ferrari; Mariano Grosso; Giuseppe Boni; Ele Ferrannini; Giuliano Mariani
Thyroid uptake of 67Ga-citrate is associated with thyroid autoimmunity and hypothyroidism in patients with sarcoidosis.
European journal of nuclear medicine and molecular imaging 2009;36(1):137-43.
2008: Alessandro Antonelli; Poupak Fallahi; Silvia Martina Ferrari; C Pupilli; G d'Annunzio; R Lorini; M Vanelli; Ele Ferrannini
Serum Th1 (CXCL10) and Th2 (CCL2) chemokine levels in children with newly diagnosed Type 1 diabetes: a longitudinal study.
Diabetic medicine : a journal of the British Diabetic Association 2008;25(11):1349-53.
2008: Alessandro Antonelli; Poupak Fallahi; Andrea Delle Sedie; Silvia Martina Ferrari; Marco Maccheroni; Stefano Bombardieri; Lucrezia Riente; Ele Ferrannini
High values of alpha (CXCL10) and beta (CCL2) circulating chemokines in patients with psoriatic arthritis, in presence or absence of autoimmune thyroiditis.
Autoimmunity 2008;41(7):537-42.
2008: A Mari; Ele Ferrannini
Beta-cell function assessment from modelling of oral tests: an effective approach.
Diabetes, obesity & metabolism 2008;10 Suppl 4():77-87.
2008: Carlo B Giorda; Angelo Avogaro; Marina Maggini; Flavia Lombardo; Edoardo Mannucci; Salvatore Turco; Stefania Spila Alegiani; Roberto Raschetti; Mario Velussi; Ele Ferrannini
Recurrence of cardiovascular events in patients with type 2 diabetes: epidemiology and risk factors.
Diabetes care 2008;31(11):2154-9.
2008: Eleonora Santini; ROBERTO LUPI; Simona Baldi; S Madec; Daniele Chimenti; Ele Ferrannini; Anna Solini
Effects of different LDL particles on inflammatory molecules in human mesangial cells.
Diabetologia 2008;51(11):2117-25.
2008: Alessandro Antonelli; Clodoveo Ferri; Poupak Fallahi; Silvia Martina Ferrari; Marco Sebastiani; Daniela Ferrari; Marco Giunti; Silvia Frascerra; Simone Tolari; Ferdinando Franzoni; Fabio Galetta; Santino Marchi; Ele Ferrannini
High values of CXCL10 serum levels in mixed cryoglobulinemia associated with hepatitis C infection.
The American journal of gastroenterology 2008;103(10):2488-94.
2008: James L Rosenzweig; Ele Ferrannini; Scott M Grundy; Steven M Haffner; Robert J Heine; Edward S Horton; Ryuzo Kawamori
Primary prevention of cardiovascular disease and type 2 diabetes in patients at metabolic risk: an endocrine society clinical practice guideline.
The Journal of clinical endocrinology and metabolism 2008;93(10):3671-89.
2008: Beverley Balkau; Leila Mhamdi; Jean-Michel Oppert; John Nolan; Alain Golay; Francesca Porcellati; Markku Laakso; Ele Ferrannini
Physical activity and insulin sensitivity: the RISC study.
Diabetes 2008;57(10):2613-8.
2008: Alessandro Antonelli; Poupak Fallahi; Simone Tolari; Silvia Martina Ferrari; Ele Ferrannini
Thyroid-associated ophthalmopathy and TSH receptor autoantibodies in nonmetastatic thyroid cancer after total thyroidectomy.
The American journal of the medical sciences 2008;336(3):288-90.
2008: Alessandro Antonelli; Clodoveo Ferri; Poupak Fallahi; Michele Colaci; Dilia Giuggioli; Silvia Martina Ferrari; Silvia Frascerra; Ferdinando Franzoni; Fabio Galetta; Ele Ferrannini
Th1 and Th2 chemokine serum levels in systemic sclerosis in the presence or absence of autoimmune thyroiditis.
The Journal of rheumatology 2008;35(9):1809-11.
2008: Alessandro Antonelli; Clodoveo Ferri; Poupak Fallahi; Silvia Martina Ferrari; Silvia Frascerra; Angelo Carpi; Andrea Nicolini; Ele Ferrannini
Alpha-chemokine CXCL10 and beta-chemokine CCL2 serum levels in patients with hepatitis C-associated cryoglobulinemia in the presence or absence of autoimmune thyroiditis.
Metabolism: clinical and experimental 2008;57(9):1270-7.
2008: Alessandro Antonelli; Silvia Martina Ferrari; Poupak Fallahi; Piero Berti; Gabriele Materazzi; Ivo Marchetti; Clara Ugolini; Fulvio Basolo; Paolo Miccoli; Ele Ferrannini
Evaluation of the sensitivity to chemotherapeutics or thiazolidinediones of primary anaplastic thyroid cancer cells obtained by fine-needle aspiration.
European journal of endocrinology / European Federation of Endocrine Societies 2008;159(3):283-91.
2008: Alessandro Antonelli; Poupak Fallahi; Mario Rotondi; Silvia Martina Ferrari; Paola Romagnani; L Ghiadoni; Mario Serio; S Taddei; Ele Ferrannini
High serum levels of CXC chemokine ligand 10 in untreated essential hypertension.
Journal of human hypertension 2008;22(8):579-81.
2008: Eleonora Santini; S Madec; V Corretti; Ele Ferrannini; Anna Solini
Effect of statins on soluble CD40 ligand in hypercholesterolemic Type 2 diabetic patients.
Journal of endocrinological investigation 2008;31(7):660-5.
2008: Michaela Kozakova; Elza Muscelli; Allan Flyvbjerg; Jan Frystyk; Carmela Morizzo; Carlo Palombo; Ele Ferrannini
Adiponectin and left ventricular structure and function in healthy adults.
The Journal of clinical endocrinology and metabolism 2008;93(7):2811-8.
2008: Alessandro Antonelli; Silvia Martina Ferrari; Poupak Fallahi; Piero Berti; Gabriele Materazzi; Lucio Barani; Ivo Marchetti; Ele Ferrannini; Paolo Miccoli
Primary cell cultures from anaplastic thyroid cancer obtained by fine-needle aspiration used for chemosensitivity tests.
Clinical endocrinology 2008;69(1):148-52.
2008: Lotfi Slimani; Nobuyuki Kudomi; Vesa Oikonen; M Jarvisalo; Jan Kiss; Alexandru Naum; Ronald Borra; Antti Viljanen; Hannu Sipila; Ele Ferrannini; Timo Savunen; Pirjo Nuutila; Patricia Iozzo
Quantification of liver perfusion with [(15)O]H(2)O-PET and its relationship with glucose metabolism and substrate levels.
Journal of hepatology 2008;48(6):974-82.
2008: Andrea Natali; Simona Baldi; Francesca Vittone; Elza Muscelli; Arturo Casolaro; C Morgantini; Carlo Palombo; Ele Ferrannini
Effects of glucose tolerance on the changes provoked by glucose ingestion in microvascular function.
Diabetologia 2008;51(5):862-71.
2008: Elza Muscelli; Andrea Mari; Arturo Casolaro; Stefania Camastra; Giuseppe Seghieri; Amalia Gastaldelli; Jens J Holst; Ele Ferrannini
Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients.
Diabetes 2008;57(5):1340-8.
2008: Alessandro Antonelli; Clodoveo Ferri; Poupak Fallahi; Silvia Martina Ferrari; Silvia Frascerra; Marco Sebastiani; Ferdinando Franzoni; Fabio Galetta; Ele Ferrannini
High values of CXCL10 serum levels in patients with hepatitis C associated mixed cryoglobulinemia in presence or absence of autoimmune thyroiditis.
Cytokine 2008;42(1):137-43.
2008: Darren K McGuire; Jeffrey R Winterfield; Jason A Rytlewski; Ele Ferrannini
Blocking the renin-angiotensin-aldosterone system to prevent diabetes mellitus.
Diabetes & vascular disease research : official journal of the International Society of Diabetes and Vascular Disease 2008;5(1):59-66.
2008: Anna Solini; Eleonora Santini; Stephanie Madec; Monica Nannipieri; Alessandra Bonotti; Sabina Cuccato; Ele Ferrannini
Rosiglitazone increases matrix production and quenches inflammation: studies in human cells.
Diabetes/metabolism research and reviews 2008;24(3):197-204.
2008: Anna Maria Sironi; Alessandro Pingitore; Sergio Ghione; Daniele De Marchi; Barbara Scattini; Positano Vincenzo; Elza Muscelli; Demetrio Ciociaro; Massimo Lombardi; Ele Ferrannini; Amalia Gastaldelli
Early hypertension is associated with reduced regional cardiac function, insulin resistance, epicardial, and visceral fat.
Hypertension 2008;51(2):282-8.
2008: Sheila Patel; Allan Flyvbjerg; Michaela Kozàkovà; Jan Frystyk; Ibrahim M Ibrahim; John R Petrie; Peter J Avery; Ele Ferrannini; Mark Walker
Variation in the ADIPOQ gene promoter is associated with carotid intima media thickness independent of plasma adiponectin levels in healthy subjects.
European heart journal 2008;29(3):386-93.
2008: David M Nathan; John B Buse; Mayer B Davidson; Ele Ferrannini; Rury R Holman; Robert S Sherwin; Bernard Zinman
Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: update regarding thiazolidinediones: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.
Diabetes care 2008;31(1):173-5.
2008: Alessandro Antonelli; Clodoveo Ferri; Poupak Fallahi; S M Ferrari; Dilia Giuggioli; Michele Colaci; A Manfredi; Silvia Frascerra; Ferdinando Franzoni; Fabio Galetta; Ele Ferrannini
CXCL10 (alpha) and CCL2 (beta) chemokines in systemic sclerosis--a longitudinal study.
Rheumatology (Oxford, England) 2008;47(1):45-9.
2008: Christian A Schneider; Ele Ferrannini; Ralph DeFronzo; Guntram Schernthaner; John Yates; Erland Erdmann
Effect of pioglitazone on cardiovascular outcome in diabetes and chronic kidney disease.
Journal of the American Society of Nephrology : JASN 2008;19(1):182-7.
2008: David M Nathan; John B Buse; Mayer B Davidson; Ele Ferrannini; Rury R Holman; Robert S Sherwin; Bernard Zinman
Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy. Update regarding the thiazolidinediones.
Diabetologia 2008;51(1):8-11.
2007: Anna Solini; Eleonora Santini; Stephanie Madec; Sabina Cuccato; Ele Ferrannini
Effects of endothelin-1 on fibroblasts from type 2 diabetic patients: Possible role in wound healing and tissue repair.
Growth factors (Chur, Switzerland) 2007;25(6):392-9.
2007: Laura Pascoe; Andrea Tura; Sheila K Patel; Ibrahim M Ibrahim; Ele Ferrannini; Eleftheria Zeggini; Michael Weedon; Andrea Mari; Andrew T Hattersley; Mark I McCarthy; Timothy M Frayling; Mark Walker
Common variants of the novel type 2 diabetes genes CDKAL1 and HHEX/IDE are associated with decreased pancreatic beta-cell function.
Diabetes 2007;56(12):3101-4.
2007: Monica Nannipieri; Alessandra Bonotti; Marco Anselmino; F Cecchetti; S Madec; E Mancini; Simona Baldi; Ferruccio Santini; Aldo Pinchera; Mauro Rossi; Ele Ferrannini
Pattern of expression of adiponectin receptors in human adipose tissue depots and its relation to the metabolic state.
International journal of obesity (2005) 2007;31(12):1843-8.
2007: Suad Efendic; Christian Boitard; Ele Ferrannini; Jean-Claude Henquin; Donald F Steiner; Erol Cerasi
Of mighty mice and diabetic men: animal models of islet dysfunction.
Diabetes, obesity & metabolism 2007;9 Suppl 2():1-4.
2007: Ele Ferrannini; Elza Muscelli; Andrea Natali; R Gabriel; A Mitrakou; A Flyvbjerg; A Golay; Kurt Højlund
Association of fasting glucagon and proinsulin concentrations with insulin resistance.
Diabetologia 2007;50(11):2342-7.
2007: Giuseppe Seghieri; Federica Tesi; Roberto Anichini; Alessandra De Bellis; E Barsotti; A Mari; Ele Ferrannini
Influence of gestational diabetes on the long-term control of glucose tolerance.
Diabetologia 2007;50(11):2234-8.
2007: Romana Femia; Michaela Kozakova; Monica Nannipieri; Clicerio Gonzales-Villalpando; Michael P Stern; Steven M Haffner; Ele Ferrannini
Carotid intima-media thickness in confirmed prehypertensive subjects: predictors and progression.
Arteriosclerosis, thrombosis, and vascular biology 2007;27(10):2244-9.
2007: Amalia Gastaldelli; Kenneth Cusi; Maura Pettiti; Jean Hardies; Yoshinori Miyazaki; Rachele Berria; Emma Buzzigoli; Anna Maria Sironi; Eugenio Cersosimo; Ele Ferrannini; Ralph DeFronzo
Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
Gastroenterology 2007;133(2):496-506.
2007: Ele Ferrannini; Beverley Balkau; Simon W Coppack; Jacqueline M Dekker; Andrea Mari; John Nolan; Mark Walker; Andrea Natali; Henning Beck-Nielsen
Insulin resistance, insulin response, and obesity as indicators of metabolic risk.
The Journal of clinical endocrinology and metabolism 2007;92(8):2885-92.
2007: Andrea Mari; Kristine B Degn; Birgitte Brock; Jørgen Rungby; Ele Ferrannini; Ole Schmitz
Effects of the long-acting human glucagon-like peptide-1 analog liraglutide on beta-cell function in normal living conditions.
Diabetes care 2007;30(8):2032-3.
2007: Alessandro Antonelli; Clodoveo Ferri; Poupak Fallahi; Alessandro Pampana; Silvia Martina Ferrari; Lucio Barani; Santino Marchi; Ele Ferrannini
Thyroid cancer in HCV-related chronic hepatitis patients: a case-control study.
Thyroid : official journal of the American Thyroid Association 2007;17(5):447-51.
2007: Angelo Avogaro; Carlo Giorda; Marina Maggini; Edoardo Mannucci; Roberto Raschetti; Flavia Lombardo; Stefania Spila Alegiani; Salvatore Turco; Mario Velussi; Ele Ferrannini
Incidence of coronary heart disease in type 2 diabetic men and women: impact of microvascular complications, treatment, and geographic location.
Diabetes care 2007;30(5):1241-7.
2007: Anna Solini; Eleonora Santini; Daniele Chimenti; Paola Chiozzi; Federico Pratesi; Sabina Cuccato; Simonetta Falzoni; ROBERTO LUPI; Ele Ferrannini; Giuseppe Pugliese; Francesco Di Virgilio
Multiple P2X receptors are involved in the modulation of apoptosis in human mesangial cells: evidence for a role of P2X4.
American journal of physiology. Renal physiology 2007;292(5):F1537-47.
2007: Stefania Camastra; Melania Manco; Andrea Mari; Aldo V Greco; Silvia Frascerra; Geltrude Mingrone; Ele Ferrannini
Beta-cell function in severely obese type 2 diabetic patients: long-term effects of bariatric surgery.
Diabetes care 2007;30(4):1002-4.
2007: Alessandro Antonelli; Clodoveo Ferri; Poupak Fallahi; Massimiliano Cazzato; Silvia Martina Ferrari; Marco Sebastiani; Ele Ferrannini
Clinical and subclinical autoimmune thyroid disorders in systemic sclerosis.
European journal of endocrinology / European Federation of Endocrine Societies 2007;156(4):431-7.
2007: Carlo Giorda; Angelo Avogaro; Marina Maggini; Flavia Lombardo; Edoardo Mannucci; Salvatore Turco; S Spila Alegiani; Roberto Raschetti; Mario Velussi; Ele Ferrannini
Incidence and risk factors for stroke in type 2 diabetic patients: the DAI study.
Stroke; a journal of cerebral circulation 2007;38(4):1154-60.
2007: Simona Baldi; Silvia Frascerra; Ele Ferrannini; Andrea Natali
LDL resistance to oxidation: effects of lipid phenotype, autologous HDL and alanine.
Clinica chimica acta; international journal of clinical chemistry 2007;379(1-2):95-100.
2007: Alessandro Antonelli; Mario Rotondi; Poupak Fallahi; Mariano Grosso; Giuseppe Boni; Silvia Martina Ferrari; Paola Romagnani; Mario Serio; Giuliano Mariani; Ele Ferrannini
Iodine-131 given for therapeutic purposes modulates differently interferon-gamma-inducible alpha-chemokine CXCL10 serum levels in patients with active Graves' disease or toxic nodular goiter.
The Journal of clinical endocrinology and metabolism 2007;92(4):1485-90.
2007: Letizia Guiducci; Tove Grönroos; Mikko J Järvisalo; Jan Kiss; Antti Viljanen; Alexandru Naum; Tapio Viljanen; Timo Savunen; Juhani Knuuti; Ele Ferrannini; Piero A Salvadori; Pirjo Nuutila; Patricia Iozzo
Biodistribution of the fatty acid analogue 18F-FTHA: plasma and tissue partitioning between lipid pools during fasting and hyperinsulinemia.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2007;48(3):455-62.
2007: Amalia Gastaldelli; Ele Ferrannini; Yoshinori Miyazaki; Masafumi Matsuda; Andrea Mari; Ralph DeFronzo
Thiazolidinediones improve beta-cell function in type 2 diabetic patients.
American journal of physiology. Endocrinology and metabolism 2007;292(3):E871-83.
2007: Ele Ferrannini
Metabolic syndrome: a solution in search of a problem.
The Journal of clinical endocrinology and metabolism 2007;92(2):396-8.
2007: Amalia Gastaldelli; Arturo Casolaro; Maura Pettiti; Monica Nannipieri; Demetrio Ciociaro; Silvia Frascerra; Emma Buzzigoli; Simona Baldi; Andrea Mari; Ele Ferrannini
Effect of pioglitazone on the metabolic and hormonal response to a mixed meal in type II diabetes.
Clinical pharmacology and therapeutics 2007;81(2):205-12.
2007: Patricia Iozzo; Mikko J Jarvisalo; Jan Kiss; Ronald Borra; Gratian A Naum; Antti Viljanen; Tapio Viljanen; Amalia Gastaldelli; Emma Buzzigoli; Letizia Guiducci; Elisabetta Barsotti; Timo Savunen; Juhani Knuuti; Merja Haaparanta-Solin; Ele Ferrannini; Pirjo Nuutila
Quantification of liver glucose metabolism by positron emission tomography: validation study in pigs.
Gastroenterology 2007;132(2):531-42.
2006: Ele Ferrannini
Keep an eye on diabetes.
Nature clinical practice. Endocrinology & metabolism 2006;2(12):649.
2006: Stefano Taddei; Nadia Caraccio; Agostino Virdis; Angela Dardano; Daniele Versari; Lorenzo Ghiadoni; Ele Ferrannini; Antonio Salvetti; Fabio Monzani
Low-grade systemic inflammation causes endothelial dysfunction in patients with Hashimoto's thyroiditis.
The Journal of clinical endocrinology and metabolism 2006;91(12):5076-82.
2006: Elza Muscelli; Andrea Mari; Andrea Natali; Brenno Astiarraga; Stefania Camastra; Silvia Frascerra; Jens J Holst; Ele Ferrannini
Impact of incretin hormones on beta-cell function in subjects with normal or impaired glucose tolerance.
American journal of physiology. Endocrinology and metabolism 2006;291(6):E1144-50.
2006: Monica Nannipieri; Rosalinda Posadas-Sánchez; Alessandra Bonotti; Ken Williams; Clicerio Gonzalez-Villalpando; Michael P Stern; Ele Ferrannini
Polymorphism of the 3'-untranslated region of the leptin receptor gene, but not the adiponectin SNP45 polymorphism, predicts type 2 diabetes: a population-based study.
Diabetes care 2006;29(11):2509-11.
2006: Mikko Kankaanpää; Hanna-Riikka Lehto; Jussi P Pärkkä; Markku Komu; Antti Viljanen; Ele Ferrannini; Juhani Knuuti; Pirjo Nuutila; Riitta Parkkola; Patricia Iozzo
Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels.
The Journal of clinical endocrinology and metabolism 2006;91(11):4689-95.
2006: Giuseppina Basta; Anna Maria Sironi; Guido Lazzerini; Serena Del Turco; Emma Buzzigoli; Arturo Casolaro; Andrea Natali; Ele Ferrannini; Amalia Gastaldelli
Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein.
The Journal of clinical endocrinology and metabolism 2006;91(11):4628-34.
2006: Alessandro Antonelli; Andrea Delle Sedie; Poupak Fallahi; Silvia Martina Ferrari; Marco Maccheroni; Ele Ferrannini; Stefano Bombardieri; Lucrezia Riente
High prevalence of thyroid autoimmunity and hypothyroidism in patients with psoriatic arthritis.
The Journal of rheumatology 2006;33(10):2026-8.
2006: Amalia Gastaldelli; Yoshinori Miyazaki; Archana Mahankali; Rachele Berria; Maura Pettiti; Emma Buzzigoli; Ele Ferrannini; Ralph DeFronzo
The effect of pioglitazone on the liver: role of adiponectin.
Diabetes care 2006;29(10):2275-81.
2006: Anna Solini; Eleonora Santini; Monica Nannipieri; Ele Ferrannini
High glucose and homocysteine synergistically affect the metalloproteinases-tissue inhibitors of metalloproteinases pattern, but not TGFB expression, in human fibroblasts.
Diabetologia 2006;49(10):2499-506.
2006: Angela Dardano; Lorenzo Ghiadoni; Yvonne Plantinga; Nadia Caraccio; Alessia Bemi; Emiliano Duranti; Stefano Taddei; Ele Ferrannini; Antonio Salvetti; Fabio Monzani
Recombinant human thyrotropin reduces endothelium-dependent vasodilation in patients monitored for differentiated thyroid carcinoma.
The Journal of clinical endocrinology and metabolism 2006;91(10):4175-8.
2006: Melania Manco; Giuseppe Nolfe; Menotti Calvani; Andrea Natali; John Nolan; Ele Ferrannini; Geltrude Mingrone
Menopause, insulin resistance, and risk factors for cardiovascular disease.
Menopause (New York, N.Y.) 2006;13(5):809-17.
2006: Alessandro Antonelli; Piera Fazzi; Poupak Fallahi; Silvia Martina Ferrari; Ele Ferrannini
Prevalence of hypothyroidism and Graves disease in sarcoidosis.
Chest 2006;130(2):526-32.
2006: Ele Ferrannini; Patricia Iozzo
Is insulin resistance atherogenic? A review of the evidence.
Atherosclerosis. Supplements 2006;7(4):5-10.
2006: Anna Solini; Eleonora Santini; Ele Ferrannini
Effect of short-term folic acid supplementation on insulin sensitivity and inflammatory markers in overweight subjects.
International journal of obesity (2005) 2006;30(8):1197-202.
2006: Johannes B Ruige; Ilse Mertens; Ellen Bartholomeeusen; Eveline Dirinck; Ele Ferrannini; Luc F Van Gaal
Fasting-based estimates of insulin sensitivity in overweight and obesity: a critical appraisal.
Obesity (Silver Spring, Md.) 2006;14(7):1250-6.
2006: Romana Femia; Andrea Natali; Antonio L'Abbate; Ele Ferrannini
Coronary atherosclerosis and alcohol consumption: angiographic and mortality data.
Arteriosclerosis, thrombosis, and vascular biology 2006;26(7):1607-12.
2006: Alessandro Antonelli; Clodoveo Ferri; Poupak Fallahi; Silvia Martina Ferrari; Alessandra Ghinoi; Mario Rotondi; Ele Ferrannini
Thyroid disorders in chronic hepatitis C virus infection.
Thyroid : official journal of the American Thyroid Association 2006;16(6):563-72.
2006: Patricia Iozzo; Amalia Gastaldelli; Mikko J Järvisalo; Jan Kiss; Ronald Borra; Emma Buzzigoli; Antti Viljanen; G Naum; Tapio Viljanen; Vesa Oikonen; Juhani Knuuti; Timo Savunen; Piero A Salvadori; Ele Ferrannini; Pirjo Nuutila
18F-FDG assessment of glucose disposal and production rates during fasting and insulin stimulation: a validation study.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(6):1016-22.
2006: Letizia Guiducci; Mikko J Järvisalo; Jan Kiss; Kjell Någren; Antti Viljanen; Alexandru Naum; Amalia Gastaldelli; Timo Savunen; Juhani Knuuti; Piero A Salvadori; Ele Ferrannini; Pirjo Nuutila; Patricia Iozzo
[11C]palmitate kinetics across the splanchnic bed in arterial, portal and hepatic venous plasma during fasting and euglycemic hyperinsulinemia.
Nuclear medicine and biology 2006;33(4):521-8.
2006: Alessandro Antonelli; Poupak Fallahi; Mario Rotondi; Silvia Martina Ferrari; Paola Romagnani; Mariano Grosso; Ele Ferrannini; Mario Serio
Increased serum CXCL10 in Graves' disease or autoimmune thyroiditis is not associated with hyper- or hypothyroidism per se, but is specifically sustained by the autoimmune, inflammatory process.
European journal of endocrinology / European Federation of Endocrine Societies 2006;154(5):651-8.
2006: Alessandro Antonelli; Mario Rotondi; Poupak Fallahi; Silvia Martina Ferrari; Aldo Paolicchi; Paola Romagnani; Mario Serio; Ele Ferrannini
Increase of CXC chemokine CXCL10 and CC chemokine CCL2 serum levels in normal ageing.
Cytokine 2006;34(1-2):32-8.
2006: Andrea Natali; Elena Toschi; stephanie baldeweg; Demetrio Ciociaro; Stefania Favilla; Luigi Saccà; Ele Ferrannini
Clustering of insulin resistance with vascular dysfunction and low-grade inflammation in type 2 diabetes.
Diabetes 2006;55(4):1133-40.
2006: Anna Solini; PF Zamboni; Angelina Passaro; Renato Fellin; Ele Ferrannini
Acute vascular events and electrolytes variations in elderly patients.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2006;38(3):197-202.
2006: Andrea Natali; Ele Ferrannini
Effects of metformin and thiazolidinediones on suppression of hepatic glucose production and stimulation of glucose uptake in type 2 diabetes: a systematic review.
Diabetologia 2006;49(3):434-41.
2006: Amalia Gastaldelli; Yoshinori Miyazaki; Maura Pettiti; Eleonora Santini; Demetrio Ciociaro; Ralph DeFronzo; Ele Ferrannini
The effect of rosiglitazone on the liver: decreased gluconeogenesis in patients with type 2 diabetes.
The Journal of clinical endocrinology and metabolism 2006;91(3):806-12.
2006: Alessandro Antonelli; Mario Rotondi; Poupak Fallahi; Paola Romagnani; Silvia Martina Ferrari; Lucio Barani; Ele Ferrannini; Mario Serio
Increase of interferon-gamma-inducible CXC chemokine CXCL10 serum levels in patients with active Graves' disease, and modulation by methimazole therapy.
Clinical endocrinology 2006;64(2):189-95.
2006: Alessandro Antonelli; Mario Rotondi; Silvia Martina Ferrari; Poupak Fallahi; Paola Romagnani; Stefano Sellari Franceschini; Mario Serio; Ele Ferrannini
Interferon-gamma-inducible alpha-chemokine CXCL10 involvement in Graves' ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists.
The Journal of clinical endocrinology and metabolism 2006;91(2):614-20.
2006: Ele Ferrannini
Is insulin resistance the cause of the metabolic syndrome?
Annals of medicine 2006;38(1):42-51.
2006: Philippe A Halban; Ele Ferrannini; Jørn Nerup
Diabetes research investment in the European Union.
Nature medicine 2006;12(1):70-2.
2005: Richard Kahn; John B Buse; Ele Ferrannini; Michael P Stern
The metabolic syndrome.
Lancet 2005;366(9501):1921-2; author reply 1923-4.
2005: Christian Boitard; Suad Efendic; Ele Ferrannini; Jean-Claude Henquin; Donald F Steiner; Erol Cerasi
A tale of two cousins: type 1 and type 2 diabetes.
Diabetes 2005;54 Suppl 2():S1-3.
2005: Mark Walker; A Mari; M K Jayapaul; S M A Bennett; Ele Ferrannini
Impaired beta cell glucose sensitivity and whole-body insulin sensitivity as predictors of hyperglycaemia in non-diabetic subjects.
Diabetologia 2005;48(12):2470-6.
2005: Antti Viljanen; Kirsi A Virtanen; Mikko J Järvisalo; Kirsti Hällsten; Riitta Parkkola; Tapani Rönnemaa; Fredrik Lönnqvist; Patricia Iozzo; Ele Ferrannini; Pirjo Nuutila
Rosiglitazone treatment increases subcutaneous adipose tissue glucose uptake in parallel with perfusion in patients with type 2 diabetes: a double-blind, randomized study with metformin.
The Journal of clinical endocrinology and metabolism 2005;90(12):6523-8.
2005: Alessandro Antonelli; Clodoveo Ferri; Poupak Fallahi; Alessandro Pampana; Silvia Martina Ferrari; Fernando Goglia; Ele Ferrannini
Hepatitis C virus infection: evidence for an association with type 2 diabetes.
Diabetes care 2005;28(10):2548-50.
2005: Amalia Gastaldelli; Anna Maria Sironi; Demetrio Ciociaro; Positano Vincenzo; Emma Buzzigoli; Daniela Giannessi; Massimo Lombardi; Andrea Mari; Ele Ferrannini
Visceral fat and beta cell function in non-diabetic humans.
Diabetologia 2005;48(10):2090-6.
2005: Alessandro Antonelli; Mario Rotondi; Poupak Fallahi; Paola Romagnani; Silvia Martina Ferrari; Ele Ferrannini; Mario Serio
Age-dependent changes in CXC chemokine ligand 10 serum levels in euthyroid subjects.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2005;25(9):547-52.
2005: Richard Kahn; John B Buse; Ele Ferrannini; Michael P Stern
The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes.
Diabetes care 2005;28(9):2289-304.
2005: Kirsi A Virtanen; Patricia Iozzo; Kirsti Hällsten; Risto Huupponen; Riitta Parkkola; Tuula Janatuinen; Fredrik Lönnqvist; Tapio Viljanen; Tapani Rönnemaa; Peter Lönnroth; Juhani Knuuti; Ele Ferrannini; Pirjo Nuutila
Increased fat mass compensates for insulin resistance in abdominal obesity and type 2 diabetes: a positron-emitting tomography study.
Diabetes 2005;54(9):2720-6.
2005: R Kahn; John B Buse; Ele Ferrannini; Michael P Stern
The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes.
Diabetologia 2005;48(9):1684-99.
2005: Stefania Camastra; Melania Manco; Andrea Mari; Simona Baldi; Amalia Gastaldelli; Aldo V Greco; Geltrude Mingrone; Ele Ferrannini
beta-cell function in morbidly obese subjects during free living: long-term effects of weight loss.
Diabetes 2005;54(8):2382-9.
2005: Geltrude Mingrone; Melania Manco; Luigi Granato; Menotti Calvani; Antonino Scarfone; Elena Valera Mora; Aldo V Greco; Hubert Vidal; Marco Castagneto; Ele Ferrannini
Leptin pulsatility in formerly obese women.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2005;19(10):1380-2.
2005: Alessandro Antonelli; Clodoveo Ferri; Poupak Fallahi; Silvia Martina Ferrari; Alessandra Ghinoi; Maria Teresa Mascia; Ele Ferrannini
[Extrahepatic manifestations of hepatitis C virus: the thyroid disorders].
Recenti progressi in medicina 2005;96(7-8):370-81.
2005: Monica Nannipieri; Clicerio Gonzales; Simona Baldi; Rosalinda Posadas-Sánchez; Ken Williams; Steven M Haffner; Michael P Stern; Ele Ferrannini
Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City diabetes study.
Diabetes care 2005;28(7):1757-62.
2005: Nadia Caraccio; Andrea Natali; Anna Maria Sironi; Simona Baldi; Silvia Frascerra; Angela Dardano; Fabio Monzani; Ele Ferrannini
Muscle metabolism and exercise tolerance in subclinical hypothyroidism: a controlled trial of levothyroxine.
The Journal of clinical endocrinology and metabolism 2005;90(7):4057-62.
2005: Nadia Caraccio; Angela Dardano; F Manfredonia; Laura Manca; Livia Pasquali; Alfonso Iudice; Luigi Murri; Ele Ferrannini; Fabio Monzani
Long-term follow-up of 106 multiple sclerosis patients undergoing interferon-beta 1a or 1b therapy: predictive factors of thyroid disease development and duration.
The Journal of clinical endocrinology and metabolism 2005;90(7):4133-7.
2005: Nadia Caraccio; Fabio Monzani; Eleonora Santini; Sabina Cuccato; Davide Ferrari; Maria Giulia Callegari; Sara Gulinelli; Cinzia Pizzirani; Francesco Di Virgilio; Ele Ferrannini; Anna Solini
Extracellular adenosine 5'-triphosphate modulates interleukin-6 production by human thyrocytes through functional purinergic P2 receptors.
Endocrinology 2005;146(7):3172-8.
2005: Maria E Valera Mora; Benedetta Simeoni; Lucilla Gagliardi; Antonino Scarfone; Giuseppe Nanni; Marco Castagneto; Melania Manco; Geltrude Mingrone; Ele Ferrannini
Predictors of weight loss and reversal of comorbidities in malabsorptive bariatric surgery.
The American journal of clinical nutrition 2005;81(6):1292-7.
2005: Andrea Mari; Amalia Gastaldelli; James Foley; Richard E Pratley; Ele Ferrannini
Beta-cell function in mild type 2 diabetic patients: effects of 6-month glucose lowering with nateglinide.
Diabetes care 2005;28(5):1132-8.
2005: Michaela Kozakova; Alan G Fraser; Simona Buralli; Armando Magagna; Antonio Salvetti; Ele Ferrannini; Carlo Palombo
Reduced left ventricular functional reserve in hypertensive patients with preserved function at rest.
Hypertension 2005;45(4):619-24.
2005: Andrea Natali; Elena Toschi; stephanie baldeweg; Arturo Casolaro; Simona Baldi; Anna Maria Sironi; John S Yudkin; Ele Ferrannini
Haematocrit, type 2 diabetes, and endothelium-dependent vasodilatation of resistance vessels.
European heart journal 2005;26(5):464-71.
2005: Ele Ferrannini
Insulin and blood pressure: connected on a circumference?
Hypertension 2005;45(3):347-8.
2005: Andrea Mari; Amalia Gastaldelli; Andrea Natali; Torben Ostergard; Ole Schmitz; Ele Ferrannini
Characterization of beta-cell function impairment in first-degree relatives of type 2 diabetic subjects: modeling analysis of 24-h triple-meal tests.
American journal of physiology. Endocrinology and metabolism 2005;288(3):E541-6.
2005: Alessandro Antonelli; Mario Rotondi; Poupak Fallahi; Paola Romagnani; Silvia Martina Ferrari; Aldo Paolicchi; Ele Ferrannini; Mario Serio
Increase of interferon-gamma inducible alpha chemokine CXCL10 but not beta chemokine CCL2 serum levels in chronic autoimmune thyroiditis.
European journal of endocrinology / European Federation of Endocrine Societies 2005;152(2):171-7.
2005: Steven E Stern; Ken Williams; Ele Ferrannini; Ralph DeFronzo; Clifton Bogardus; Michael P Stern
Identification of individuals with insulin resistance using routine clinical measurements.
Diabetes 2005;54(2):333-9.
2005: Anna Solini; Eleonora Santini; Ele Ferrannini
Enhanced angiotensin II-mediated effects in fibroblasts of patients with familial hypercholesterolemia.
Journal of hypertension 2005;23(2):367-74.
2005: Hanspeter Brunner; John R Cockcroft; John Deanfield; Ann Donald; Ele Ferrannini; julian halcox; Wolfgang Kiowski; Thomas F Lüscher; Giuseppe Mancia; Andrea Natali; James J Oliver; Achille C Pessina; Damiano Rizzoni; Gian Paolo Rossi; Antonio Salvetti; Lukas E Spieker; Stefano Taddei; David J Webb
Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension.
Journal of hypertension 2005;23(2):233-46.
2005: Nadia Caraccio; Riccardo Giannini; Sabina Cuccato; Pinuccia Faviana; Piero Berti; David Galleri; Angela Dardano; Fulvio Basolo; Ele Ferrannini; Fabio Monzani
Type I interferons modulate the expression of thyroid peroxidase, sodium/iodide symporter, and thyroglobulin genes in primary human thyrocyte cultures.
The Journal of clinical endocrinology and metabolism 2005;90(2):1156-62.
2005: Elza Muscelli; Geltrude Mingrone; Stefania Camastra; Melania Manco; Juliano Alves Pereira; José Carlos Pareja; Ele Ferrannini
Differential effect of weight loss on insulin resistance in surgically treated obese patients.
The American journal of medicine 2005;118(1):51-7.
2005: Ele Ferrannini
Rosiglitazone and lipid metabolism.
Diabetologia 2005;48(1):6-7.
2005: Ele Ferrannini; Amalia Gastaldelli; Yoshinori Miyazaki; Masafumi Matsuda; Andrea Mari; Ralph DeFronzo
beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis.
The Journal of clinical endocrinology and metabolism 2005;90(1):493-500.
2004: Eleonora Santini; Poupak Fallahi; Silvia Martina Ferrari; Antonio Masoni; Alessandro Antonelli; Ele Ferrannini
Effect of PPAR-gamma activation and inhibition on glucose-stimulated insulin release in INS-1e cells.
Diabetes 2004;53 Suppl 3():S79-83.
2004: Ele Ferrannini; Stefania Camastra; Amalia Gastaldelli; Anna Maria Sironi; Andrea Natali; Elza Muscelli; Geltrude Mingrone; Andrea Mari
beta-cell function in obesity: effects of weight loss.
Diabetes 2004;53 Suppl 3():S26-33.
2004: Jean-Claude Henquin; Christian Boitard; Erol Cerasi; Ele Ferrannini; Donald F Steiner; Suad Efendic
Impact of treatment on islet function in type 2 diabetes.
Diabetes 2004;53 Suppl 3():S1-5.
2004: Alessandro Antonelli; Mario Rotondi; Poupak Fallahi; Paola Romagnani; Silvia Martina Ferrari; Andrea Buonamano; Ele Ferrannini; Mario Serio
High levels of circulating CXC chemokine ligand 10 are associated with chronic autoimmune thyroiditis and hypothyroidism.
The Journal of clinical endocrinology and metabolism 2004;89(11):5496-9.
2004: Patricia Iozzo; Teemu Takala; Vesa Oikonen; Jörgen Bergman; Tove Grönroos; Ele Ferrannini; Pirjo Nuutila; Juhani Knuuti
Effect of training status on regional disposal of circulating free fatty acids in the liver and skeletal muscle during physiological hyperinsulinemia.
Diabetes care 2004;27(9):2172-7.
2004: Amalia Gastaldelli; Yoshinori Miyazaki; Maura Pettiti; Emma Buzzigoli; Srikanth Mahankali; Ele Ferrannini; Ralph DeFronzo
Separate contribution of diabetes, total fat mass, and fat topography to glucose production, gluconeogenesis, and glycogenolysis.
The Journal of clinical endocrinology and metabolism 2004;89(8):3914-21.
2004: Anna Maria Sironi; Amalia Gastaldelli; Andrea Mari; Demetrio Ciociaro; Positano Vincenzo; Vincenzo Postano; Emma Buzzigoli; Sergio Ghione; Stefano Turchi; Massimo Lombardi; Ele Ferrannini
Visceral fat in hypertension: influence on insulin resistance and beta-cell function.
Hypertension 2004;44(2):127-33.
2004: Alessandro Antonelli; Clodoveo Ferri; Poupak Fallahi; Dilia Giuggioli; Claudia Nesti; Giovanni Longombardo; Patrizia Fadda; Alessandro Pampana; Marco Maccheroni; Ele Ferrannini
Thyroid involvement in patients with overt HCV-related mixed cryoglobulinaemia.
QJM : monthly journal of the Association of Physicians 2004;97(8):499-506.
2004: Alessandro Antonelli; Ele Ferrannini
CD38 autoimmunity: recent advances and relevance to human diabetes.
Journal of endocrinological investigation 2004;27(7):695-707.
2004: Patricia Iozzo; R Lautamaki; F Geisler; Kirsi A Virtanen; Vesa Oikonen; Merja Haaparanta; H Yki-Jarvinen; Ele Ferrannini; Juhani Knuuti; Pirjo Nuutila
Non-esterified fatty acids impair insulin-mediated glucose uptake and disposition in the liver.
Diabetologia 2004;47(7):1149-56.
2004: Patricia Iozzo; Anu K Turpeinen; Teemu Takala; Vesa Oikonen; Jörgen Bergman; Tove Grönroos; Ele Ferrannini; Pirjo Nuutila; Juhani Knuuti
Defective liver disposal of free fatty acids in patients with impaired glucose tolerance.
The Journal of clinical endocrinology and metabolism 2004;89(7):3496-502.
2004: Alessandro Antonelli; Clodoveo Ferri; Alessandro Pampana; Poupak Fallahi; Claudia Nesti; Martina Pasquini; Santino Marchi; Ele Ferrannini
Thyroid disorders in chronic hepatitis C.
The American journal of medicine 2004;117(1):10-3.
2004: Anna Solini; Angelina Passaro; Paola Fioretto; Monica Nannipieri; Ele Ferrannini
Lipoprotein lipase gene variants and progression of nephropathy in hypercholesterolaemic patients with type 2 diabetes.
Journal of internal medicine 2004;256(1):30-6.
2004: Andrea Natali; stephanie baldeweg; Elena Toschi; Brunella Capaldo; Daniele Barbaro; Amalia Gastaldelli; John S Yudkin; Ele Ferrannini
Vascular effects of improving metabolic control with metformin or rosiglitazone in type 2 diabetes.
Diabetes care 2004;27(6):1349-57.
2004: Andrea Natali; Ele Ferrannini
Hypertension, insulin resistance, and the metabolic syndrome.
Endocrinology and metabolism clinics of North America 2004;33(2):417-29.
2004: Fabio Monzani; Nadia Caraccio; M Kozàkowà; Angela Dardano; Francesca Vittone; Agostino Virdis; Stefano Taddei; Carlo Palombo; Ele Ferrannini
Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo- controlled study.
The Journal of clinical endocrinology and metabolism 2004;89(5):2099-106.
2004: Ele Ferrannini; Andrea Mari
Beta cell function and its relation to insulin action in humans: a critical appraisal.
Diabetologia 2004;47(5):943-56.
2004: Fabio Monzani; Nadia Caraccio; Angela Dardano; Ele Ferrannini
Thyroid autoimmunity and dysfunction associated with type I interferon therapy.
Clinical and experimental medicine 2004;3(4):199-210.
2004: Mary Aparecida C T Lazarin; João R Bennini; Carlos L C Pereira; Brenno Astiarraga; Ele Ferrannini; Elza Muscelli
Normal insulin sensitivity in lean offspring of obese parents.
Obesity research 2004;12(4):621-6.
2004: S A Hills; Beverley Balkau; Simon W Coppack; J M Dekker; Andrea Mari; Andrea Natali; M Walker; Ele Ferrannini
The EGIR-RISC STUDY (The European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): I. Methodology and objectives.
Diabetologia 2004;47(3):566-70.
2004: Ferdinando Franzoni; Fabio Galetta; Carmela Morizzo; Valter Lubrano; Carlo Palombo; Gino Santoro; Ele Ferrannini; Alfredo Quiñones-Galvan
Effects of age and physical fitness on microcirculatory function.
Clinical science (London, England : 1979) 2004;106(3):329-35.
2004: Christian Boitard; Erol Cerasi; Suad Efendic; Jean-Claude Henquin; Donald F Steiner; Ele Ferrannini
Novel factors in the regulation of beta-cell function.
Diabetes 2004;53 Suppl 1():S1-3.
2004: Alessandro Antonelli; Clodoveo Ferri; Poupak Fallahi; Marco Sebastiani; Claudia Nesti; Lucio Barani; Roberto Barale; Ele Ferrannini
Type 2 diabetes in hepatitis C-related mixed cryoglobulinaemia patients.
Rheumatology (Oxford, England) 2004;43(2):238-40.
2004: Ele Ferrannini; Monica Nannipieri; Ken Williams; Clicerio Gonzales; Steve M Haffner; Michael P Stern
Mode of onset of type 2 diabetes from normal or impaired glucose tolerance.
Diabetes 2004;53(1):160-5.
2004: Amalia Gastaldelli; Ele Ferrannini; Yoshinori Miyazaki; Masafumi Matsuda; Ralph DeFronzo
Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study.
Diabetologia 2004;47(1):31-9.
2003: Ele Ferrannini; Jaakko Tuomilehto
Dyslipidaemia versus endothelial dysfunction: which is more important in the development of vascular disease?
International journal of clinical practice. Supplement 2003;(137):5-14.
2003: Michaela Kozàkovà; Ele Ferrannini; Carlo Palombo
Relation between left ventricular midwall function and coronary vasodilator capacity in arterial hypertension.
Hypertension 2003;42(4):528-33.
2003: Ele Ferrannini
Analysis of data on insulin resistance from the European group for the study of insulin resistance: focus on obesity and hypertension.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2003;9 Suppl 2():43-9.
2003: Ele Ferrannini; Amalia Gastaldelli; Yoshinori Miyazaki; Masafumi Matsuda; Maura Pettiti; Andrea Natali; Andrea Mari; Ralph DeFronzo
Predominant role of reduced beta-cell sensitivity to glucose over insulin resistance in impaired glucose tolerance.
Diabetologia 2003;46(9):1211-9.
2003: Ferdinando Franzoni; Alfredo Quiñones-Galvan; Francesco Regoli; Ele Ferrannini; Fabio Galetta
A comparative study of the in vitro antioxidant activity of statins.
International journal of cardiology 2003;90(2-3):317-21.
2003: Stefano Taddei; Nadia Caraccio; Agostino Virdis; Angela Dardano; Daniele Versari; Lorenzo Ghiadoni; Antonio Salvetti; Ele Ferrannini; Fabio Monzani
Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy.
The Journal of clinical endocrinology and metabolism 2003;88(8):3731-7.
2003: Ele Ferrannini; Michaela Kozàkovà
Metabolic effects of antihypertensive treatment: long live the debate.
Journal of hypertension 2003;21(8):1459-62.
2003: Patricia Iozzo; Anu K Turpeinen; Teemu Takala; Vesa Oikonen; Olof Solin; Ele Ferrannini; Pirjo Nuutila; Juhani Knuuti
Liver uptake of free fatty acids in vivo in humans as determined with 14( R, S)-[18F]fluoro-6-thia-heptadecanoic acid and PET.
European journal of nuclear medicine and molecular imaging 2003;30(8):1160-4.
2003: Ele Ferrannini; Amalia Gastaldelli; Masafumi Matsuda; Yoshinori Miyazaki; Maura Pettiti; Leonard Glass; Ralph DeFronzo
Influence of ethnicity and familial diabetes on glucose tolerance and insulin action: a physiological analysis.
The Journal of clinical endocrinology and metabolism 2003;88(7):3251-7.
2003: Patricia Iozzo; Kirsti Hallsten; Vesa Oikonen; Kirsi A Virtanen; Riitta Parkkola; Jukka Kemppainen; Olof Solin; Fredrik Lonnqvist; Ele Ferrannini; Juhani Knuuti; Pirjo Nuutila
Effects of metformin and rosiglitazone monotherapy on insulin-mediated hepatic glucose uptake and their relation to visceral fat in type 2 diabetes.
Diabetes care 2003;26(7):2069-74.
2003: Michaela Kozàkovà; Carmela Morizzo; Ele Ferrannini; Carlo Palombo
Coronary vasodilator capacity and exercise-induced myocardial ischemia are related to the pulsatile component of blood pressure in patients with essential hypertension.
Journal of hypertension 2003;21(7):1407-14.
2003: Alessandro Antonelli; Paolo Miccoli; Poupak Fallahi; Mariano Grosso; Claudia Nesti; Claudio Spinelli; Ele Ferrannini
Role of neck ultrasonography in the follow-up of children operated on for thyroid papillary cancer.
Thyroid : official journal of the American Thyroid Association 2003;13(5):479-84.
2003: Patricia Iozzo; Fabian Geisler; Vesa Oikonen; Maija Mäki; Teemu Takala; Olof Solin; Ele Ferrannini; Juhani Knuuti; Pirjo Nuutila
Insulin stimulates liver glucose uptake in humans: an 18F-FDG PET Study.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2003;44(5):682-9.
2003: Patricia Iozzo; Kirsti Hallsten; Vesa Oikonen; Kirsi A Virtanen; Jukka Kemppainen; Olof Solin; Ele Ferrannini; Juhani Knuuti; Pirjo Nuutila
Insulin-mediated hepatic glucose uptake is impaired in type 2 diabetes: evidence for a relationship with glycemic control.
The Journal of clinical endocrinology and metabolism 2003;88(5):2055-60.
2003: Andrea Natali; Antonio L'Abbate; Ele Ferrannini
Erythrocyte sedimentation rate, coronary atherosclerosis, and cardiac mortality.
European heart journal 2003;24(7):639-48.
2003: Monica Nannipieri; Rosalinda Posadas-Sánchez; Ken Williams; Eudokia N Politi; C Gonzales-Villalpando; Michael P Stern; Ele Ferrannini
Association between polymorphisms of the atrial natriuretic peptide gene and proteinuria: a population-based study.
Diabetologia 2003;46(3):429-32.
2002: Piero Marchetti; Alessandro Antonelli; ROBERTO LUPI; Lorella Marselli; Poupak Fallahi; Claudia Nesti; Germano Baj; Ele Ferrannini
Prolonged in vitro exposure to autoantibodies against CD38 impairs the function and survival of human pancreatic islets.
Diabetes 2002;51 Suppl 3():S474-7.
2002: Alfredo Quiñones-Galvan; Antonio Pucciarelli; Demetrio Ciociaro; Antonio Masoni; Ferdinando Franzoni; Andrea Natali; Ele Ferrannini
Metabolic effects of combined antihypertensive treatment in patients with essential hypertension.
Journal of cardiovascular pharmacology 2002;40(6):916-21.
2002: Andrea Mari; Ole Schmitz; Amalia Gastaldelli; Torben Oestergaard; Birgit Nyholm; Ele Ferrannini
Meal and oral glucose tests for assessment of beta -cell function: modeling analysis in normal subjects.
American journal of physiology. Endocrinology and metabolism 2002;283(6):E1159-66.
2002: Amalia Gastaldelli; Yoshinori Miyazaki; Maura Pettiti; Masafumi Matsuda; Srikanth Mahankali; Eleonora Santini; Ralph DeFronzo; Ele Ferrannini
Metabolic effects of visceral fat accumulation in type 2 diabetes.
The Journal of clinical endocrinology and metabolism 2002;87(11):5098-103.
2002: Patricia Iozzo; Panithaya Chareonthaitawee; Ornella E Rimoldi; D John Betteridge; Paolo G Camici; Ele Ferrannini
Mismatch between insulin-mediated glucose uptake and blood flow in the heart of patients with Type II diabetes.
Diabetologia 2002;45(10):1404-9.
2002: Patricia Iozzo; Panithaya Chareonthaitawee; David Dutka; D John Betteridge; Ele Ferrannini; Paolo G Camici
Independent association of type 2 diabetes and coronary artery disease with myocardial insulin resistance.
Diabetes 2002;51(10):3020-4.
2002: Alessandro Antonelli; T Tuomi; Monica Nannipieri; Poupak Fallahi; Claudia Nesti; H Okamoto; L Groop; Ele Ferrannini
Autoimmunity to CD38 and GAD in Type I and Type II diabetes: CD38 and HLA genotypes and clinical phenotypes.
Diabetologia 2002;45(9):1298-306.
2002: Ele Ferrannini; Beverley Balkau
Insulin: in search of a syndrome.
Diabetic medicine : a journal of the British Diabetic Association 2002;19(9):724-9.
2002: Fabio Monzani; Giuseppe Meucci; Nadia Caraccio; Michela Saviozzi; Arturo Casolaro; Gianluca Moscato; Francesco Lombardo; Serena Mosti; Carolina Scagnolari; Fabrizio Bruschi; Guido Antonelli; Ele Ferrannini; Luigi Murri
Discordant effect of IFN-beta1a therapy on anti-IFN antibodies and thyroid disease development in patients with multiple sclerosis.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2002;22(7):773-81.
2002: Gabriele Siciliano; Fabio Monzani; Maria Laura Manca; Alessandra Tessa; Nadia Caraccio; Giulia Tozzi; Fiorella Piemonte; Michelangelo Mancuso; Filippo M Santorelli; Ele Ferrannini; Luigi Murri
Human mitochondrial transcription factor A reduction and mitochondrial dysfunction in Hashimoto's hypothyroid myopathy.
Molecular medicine (Cambridge, Mass.) 2002;8(6):326-33.
2002: Monica Nannipieri; Giuseppe Seghieri; C Catalano; T Prontera; Simona Baldi; Ele Ferrannini
Defective regulation and action of atrial natriuretic peptide in type 2 diabetes.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2002;34(5):265-70.
2002: Patricia Iozzo; Panithaya Chareonthaitawee; Marco Di Terlizzi; D John Betteridge; Ele Ferrannini; Paolo G Camici
Regional myocardial blood flow and glucose utilization during fasting and physiological hyperinsulinemia in humans.
American journal of physiology. Endocrinology and metabolism 2002;282(5):E1163-71.
2002: Nadia Caraccio; Ele Ferrannini; Fabio Monzani
Lipoprotein profile in subclinical hypothyroidism: response to levothyroxine replacement, a randomized placebo-controlled study.
The Journal of clinical endocrinology and metabolism 2002;87(4):1533-8.
2002: Andrea Mari; Andrea Tura; Amalia Gastaldelli; Ele Ferrannini
Assessing insulin secretion by modeling in multiple-meal tests: role of potentiation.
Diabetes 2002;51 Suppl 1():S221-6.
2002: Elena Toschi; Stefania Camastra; Anna Maria Sironi; Antonio Masoni; Amalia Gastaldelli; Andrea Mari; Ele Ferrannini; Andrea Natali
Effect of acute hyperglycemia on insulin secretion in humans.
Diabetes 2002;51 Suppl 1():S130-3.
2002: Jean-Claude Henquin; Christian Boitard; Suad Efendic; Ele Ferrannini; Donald F Steiner; Erol Cerasi
Insulin secretion: movement at all levels.
Diabetes 2002;51 Suppl 1():S1-2.
2002: Aldo V Greco; Geltrude Mingrone; Annalisa Giancaterini; Melania Manco; Manrico Morroni; Saverio Cinti; Marnie Granzotto; Roberto Vettor; Stefania Camastra; Ele Ferrannini
Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion.
Diabetes 2002;51(1):144-51.
2001: Alessandro Antonelli; Poupak Fallahi; Claudia Nesti; C Pupilli; Piero Marchetti; S Takasawa; H Okamoto; Ele Ferrannini
Anti-CD38 autoimmunity in patients with chronic autoimmune thyroiditis or Graves' disease.
Clinical and experimental immunology 2001;126(3):426-31.
2001: William C Schumann; Amalia Gastaldelli; Visvanathan Chandramouli; Stephen Previs; Maura Pettiti; Ele Ferrannini; Bernard R Landau
Determination of the enrichment of the hydrogen bound to carbon 5 of glucose on 2H2O administration.
Analytical biochemistry 2001;297(2):195-7.
2001: Alfredo Quiñones-Galvan; A Pucciarelli; Anna Fratta Pasini; Ulisse Garbin; Ferdinando Franzoni; Fabio Galetta; Andrea Natali; Luciano Cominacini; Ele Ferrannini
Effective blood pressure treatment improves LDL-cholesterol susceptibility to oxidation in patients with essential hypertension.
Journal of internal medicine 2001;250(4):322-6.
2001: Amalia Gastaldelli; Elena Toschi; Maura Pettiti; Silvia Frascerra; Alfredo Quiñones-Galvan; Anna Maria Sironi; Andrea Natali; Ele Ferrannini
Effect of physiological hyperinsulinemia on gluconeogenesis in nondiabetic subjects and in type 2 diabetic patients.
Diabetes 2001;50(8):1807-12.
2001: Monica Nannipieri; M Manganiello; A Pezzatini; A De Bellis; Giuseppe Seghieri; Ele Ferrannini
Polymorphisms in the hANP (human atrial natriuretic peptide) gene, albuminuria, and hypertension.
Hypertension 2001;37(6):1416-22.
2001: Alessandro Antonelli; Germano Baj; Piero Marchetti; Poupak Fallahi; Nicola Surico; C Pupilli; Fabio Malavasi; Ele Ferrannini
Human anti-CD38 autoantibodies raise intracellular calcium and stimulate insulin release in human pancreatic islets.
Diabetes 2001;50(5):985-91.
2001: Yoshinori Miyazaki; Archana Mahankali; Masafumi Matsuda; Leonard Glass; Srikanth Mahankali; Ele Ferrannini; Kenneth Cusi; Lawrence J. Manderino; Ralph DeFronzo
Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazone.
Diabetes care 2001;24(4):710-9.
2001: Fabio Monzani; Vitantonio Di Bello; Nadia Caraccio; Alessio Bertini; Davide Giorgi; Costantino Giusti; Ele Ferrannini
Effect of levothyroxine on cardiac function and structure in subclinical hypothyroidism: a double blind, placebo-controlled study.
The Journal of clinical endocrinology and metabolism 2001;86(3):1110-5.
2001: Alfredo Quiñones-Galvan; Ele Ferrannini
Metabolic effects of glucose-insulin infusions: myocardium and whole body.
Current opinion in clinical nutrition and metabolic care 2001;4(2):157-63.
2001: Elena Toschi; Stefania Camastra; Andrea Mari; Amalia Gastaldelli; Simona Baldi; Antonio Masoni; Ele Ferrannini
A model for assessing insulin secretion and its control under free-living conditions.
Diabetes 2001;50 Suppl 1():S178-9.
2001: Andrea Mari; Stefania Camastra; Elena Toschi; Annalisa Giancaterini; Amalia Gastaldelli; Geltrude Mingrone; Ele Ferrannini
A model for glucose control of insulin secretion during 24 h of free living.
Diabetes 2001;50 Suppl 1():S164-8.
2001: Michele Emdin; Amalia Gastaldelli; Elza Muscelli; Alberto Macerata; Andrea Natali; Stefania Camastra; Ele Ferrannini
Hyperinsulinemia and autonomic nervous system dysfunction in obesity: effects of weight loss.
Circulation 2001;103(4):513-9.
2001: Monica Nannipieri; A Lanfranchi; D Santerini; C Catalano; GERALD VAN DE WERVE; Ele Ferrannini
Influence of long-term diabetes on renal glycogen metabolism in the rat.
Nephron 2001;87(1):50-7.
2000: Amalia Gastaldelli; Michele Emdin; F Conforti; Stefania Camastra; Ele Ferrannini
Insulin prolongs the QTc interval in humans.
American journal of physiology. Regulatory, integrative and comparative physiology 2000;279(6):R2022-5.
2000: Andrea Natali; Anna Maria Sironi; Elena Toschi; Stefania Camastra; G Sanna; A Perissinotto; Stefano Taddei; Ele Ferrannini
Effect of vitamin C on forearm blood flow and glucose metabolism in essential hypertension.
Arteriosclerosis, thrombosis, and vascular biology 2000;20(11):2401-6.
2000: AQ Galvan; Fabio Galetta; Andrea Natali; Elza Muscelli; Anna Maria Sironi; G Cini; Stefania Camastra; Ele Ferrannini
Insulin resistance and hyperinsulinemia: No independent relation to left ventricular mass in humans.
Circulation 2000;102(18):2233-8.
2000: Andrea Natali; Elena Toschi; Stefania Camastra; Amalia Gastaldelli; L Groop; Ele Ferrannini
Determinants of postabsorptive endogenous glucose output in non-diabetic subjects. European Group for the Study of Insulin Resistance (EGIR).
Diabetologia 2000;43(10):1266-72.
2000: Fabio Monzani; Nadia Caraccio; Arturo Casolaro; Francesco Lombardo; Gianluca Moscato; Luigi Murri; Ele Ferrannini; Giuseppe Meucci
Long-term interferon beta-1b therapy for MS: is routine thyroid assessment always useful?
Neurology 2000;55(4):549-52.
2000: Amalia Gastaldelli; Simona Baldi; Maura Pettiti; Elena Toschi; Stefania Camastra; Andrea Natali; Bernard R Landau; Ele Ferrannini
Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study.
Diabetes 2000;49(8):1367-73.
2000: Ele Ferrannini
Insulin resistance, iron, and the liver.
Lancet 2000;355(9222):2181-2.
2000: Andrea Natali; S Vichi; Patrizia Landi; S Severi; Antonio L'Abbate; Ele Ferrannini
Coronary atherosclerosis in Type II diabetes: angiographic findings and clinical outcome.
Diabetologia 2000;43(5):632-41.
2000: Andrea Natali; Amalia Gastaldelli; Stefania Camastra; Anna Maria Sironi; Elena Toschi; Antonio Masoni; Ele Ferrannini; Andrea Mari
Dose-response characteristics of insulin action on glucose metabolism: a non-steady-state approach.
American journal of physiology. Endocrinology and metabolism 2000;278(5):E794-801.
2000: Andrea Natali; S Vichi; Patrizia Landi; Elena Toschi; S Severi; Antonio L'Abbate; Ele Ferrannini
Coronary artery disease and arterial hypertension: clinical, angiographic and follow-up data.
Journal of internal medicine 2000;247(2):219-30.
1999: Stefania Camastra; E Bonora; Stefano Del Prato; K Rett; M Weck; Ele Ferrannini
Effect of obesity and insulin resistance on resting and glucose-induced thermogenesis in man. EGIR (European Group for the Study of Insulin Resistance).
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1999;23(12):1307-13.
1999: Alfredo Quiñones-Galvan; Anna Maria Sironi; Simona Baldi; Fabio Galetta; Ulisse Garbin; Anna Fratta Pasini; Luciano Cominacini; Ele Ferrannini
Evidence that acute insulin administration enhances LDL cholesterol susceptibility to oxidation in healthy humans.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(12):2928-32.
1999: Ele Ferrannini; AQ Galvan; Amalia Gastaldelli; Stefania Camastra; Anna Maria Sironi; Elena Toschi; Simona Baldi; Silvia Frascerra; Fabio Monzani; Alessandro Antonelli; Monica Nannipieri; Andrea Mari; Giuseppe Seghieri; Andrea Natali
Insulin: new roles for an ancient hormone.
European journal of clinical investigation 1999;29(10):842-52.
1999: Gabriele Siciliano; MR Renna; Maria Laura Manca; Concetta Prontera; Gian Carlo Zucchelli; Ele Ferrannini; Luigi Murri
The relationship of plasma catecholamine and lactate during anaerobic threshold exercise in mitochondrial myopathies.
Neuromuscular disorders : NMD 1999;9(6-7):411-6.
1999: Fabio Monzani; Nadia Caraccio; Giuseppe Meucci; Francesco Lombardo; Gianluca Moscato; Arturo Casolaro; Marco Ferdeghini; Luigi Murri; Ele Ferrannini
Effect of 1-year treatment with interferon-beta1b on thyroid function and autoimmunity in patients with multiple sclerosis.
European journal of endocrinology / European Federation of Endocrine Societies 1999;141(4):325-31.
1999: Fabio Monzani; Nadia Caraccio; P Del Guerra; Arturo Casolaro; Ele Ferrannini
Neuromuscular symptoms and dysfunction in subclinical hypothyroid patients: beneficial effect of L-T4 replacement therapy.
Clinical endocrinology 1999;51(2):237-42.
1999: Amalia Gastaldelli; R Mammoliti; Elza Muscelli; Stefania Camastra; Luigi Landini; Ele Ferrannini; Michele Emdin
Linear and nonlinear properties of heart rate variability: influence of obesity.
Annals of the New York Academy of Sciences 1999;879():249-54.
1999: Geltrude Mingrone; F L Henriksen; Aldo V Greco; L N Krogh; Esmeralda Capristo; A Gastaldelli; Marco Castagneto; Ele Ferrannini; Giovanni Gasbarrini; H Beck-Nielsen
Triglyceride-induced diabetes associated with familial lipoprotein lipase deficiency.
Diabetes 1999;48(6):1258-63.
1999: Brunella Capaldo; Amalia Gastaldelli; S Antoniello; M Auletta; F Pardo; Demetrio Ciociaro; R Guida; Ele Ferrannini; Luigi Saccà
Splanchnic and leg substrate exchange after ingestion of a natural mixed meal in humans.
Diabetes 1999;48(5):958-66.
1999: P Iozzo; H Beck-Nielsen; M Laakso; U Smith; Hannele Yki-Järvinen; Ele Ferrannini
Independent influence of age on basal insulin secretion in nondiabetic humans. European Group for the Study of Insulin Resistance.
The Journal of clinical endocrinology and metabolism 1999;84(3):863-8.
1998: Ele Ferrannini; Stefania Camastra
Relationship between impaired glucose tolerance, non-insulin-dependent diabetes mellitus and obesity.
European journal of clinical investigation 1998;28 Suppl 2():3-6; discussion 6-7.
1998: Ele Ferrannini; Andrea Mari
How to measure insulin sensitivity.
Journal of hypertension 1998;16(7):895-906.
1998: Elza Muscelli; Michele Emdin; Andrea Natali; Lorenza Pratali; Stefania Camastra; Amalia Gastaldelli; Simona Baldi; Clara Carpeggiani; Ele Ferrannini
Autonomic and hemodynamic responses to insulin in lean and obese humans.
The Journal of clinical endocrinology and metabolism 1998;83(6):2084-90.
1998: Elza Muscelli; Stefania Camastra; Amalia Gastaldelli; Andrea Natali; Antonio Masoni; N Pecori; Ele Ferrannini
Influence of duration of obesity on the insulin resistance of obese non-diabetic patients.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1998;22(3):262-7.
1998: Andrea Natali; Alfredo Quiñones-Galvan; N Pecori; G Sanna; Elena Toschi; Ele Ferrannini
Vasodilation with sodium nitroprusside does not improve insulin action in essential hypertension.
Hypertension 1998;31(2):632-6.
1998: Andrea Natali; Amalia Gastaldelli; AQ Galvan; Anna Maria Sironi; Demetrio Ciociaro; G Sanna; P Rosenzweig; Ele Ferrannini
Effects of acute alpha 2-blockade on insulin action and secretion in humans.
The American journal of physiology 1998;274(1 Pt 1):E57-64.
1998: Luciano Cominacini; Ulisse Garbin; Anna Fratta Pasini; Mario Campagnola; Anna Davoli; E Foot; G Sighieri; Anna Maria Sironi; Vincenzo Lo Cascio; Ele Ferrannini
Troglitazone reduces LDL oxidation and lowers plasma E-selectin concentration in NIDDM patients.
Diabetes 1998;47(1):130-3.
1997: Ele Ferrannini; Andrea Natali; Brunella Capaldo; Mikko Lehtovirta; S Jacob; Hannele Yki-Järvinen
Insulin resistance, hyperinsulinemia, and blood pressure: role of age and obesity. European Group for the Study of Insulin Resistance (EGIR).
Hypertension 1997;30(5):1144-9.
1997: Fabio Monzani; Nadia Caraccio; Gabriele Siciliano; Laura Manca; Luigi Murri; Ele Ferrannini
Clinical and biochemical features of muscle dysfunction in subclinical hypothyroidism.
The Journal of clinical endocrinology and metabolism 1997;82(10):3315-8.
1997: Elza Muscelli; Stefania Camastra; C Catalano; AQ Galvan; Demetrio Ciociaro; Simona Baldi; Ele Ferrannini
Metabolic and cardiovascular assessment in moderate obesity: effect of weight loss.
The Journal of clinical endocrinology and metabolism 1997;82(9):2937-43.
1997: Andrea Natali; Stefano Taddei; Alfredo Quiñones-Galvan; Stefania Camastra; Simona Baldi; Silvia Frascerra; Agostino Virdis; Isabella Sudano; Antonio Salvetti; Ele Ferrannini
Insulin sensitivity, vascular reactivity, and clamp-induced vasodilatation in essential hypertension.
Circulation 1997;96(3):849-55.
1997: Anna Maria Sironi; S Vichi; Amalia Gastaldelli; N Pecori; Roberto Anichini; E Foot; Giuseppe Seghieri; Ele Ferrannini
Effects of troglitazone on insulin action and cardiovascular risk factors in patients with non-insulin-dependent diabetes.
Clinical pharmacology and therapeutics 1997;62(2):194-202.
1997: Alfredo Quiñones-Galvan; Ele Ferrannini
Renal effects of insulin in man.
Journal of nephrology 1997;10(4):188-91.
1997: Ele Ferrannini; Stefania Camastra; S W Coppack; D Fliser; A Golay; A Mitrakou
Insulin action and non-esterified fatty acids. The European Group for the Study of Insulin Resistance (EGIR).
The Proceedings of the Nutrition Society 1997;56(2):753-61.
1997: C Catalano; Elza Muscelli; Andrea Natali; ALESSANDRO MAZZONI; Antonio Masoni; B Bernardini; Giuseppe Seghieri; Ele Ferrannini
Reciprocal association between insulin sensitivity and the haematocrit in man.
European journal of clinical investigation 1997;27(7):634-7.
1997: Ele Ferrannini
Insulin resistance is central to the burden of diabetes.
Diabetes/metabolism reviews 1997;13(2):81-6.
1997: C Catalano; Elza Muscelli; Alfredo Quiñones-Galvan; Simona Baldi; Antonio Masoni; I Gibb; O Torffvit; Giuseppe Seghieri; Ele Ferrannini
Effect of insulin on systemic and renal handling of albumin in nondiabetic and NIDDM subjects.
Diabetes 1997;46(5):868-75.
1996: Simona Baldi; Andrea Natali; G Buzzigoli; AQ Galvan; Anna Maria Sironi; Ele Ferrannini
In vivo effect of insulin on intracellular calcium concentrations: relation to insulin resistance.
Metabolism: clinical and experimental 1996;45(11):1402-7.
1996: Elza Muscelli; Stefania Camastra; Antonio Masoni; Simona Baldi; Anna Maria Sironi; Andrea Natali; Ele Ferrannini
Acute insulin administration does not affect plasma leptin levels in lean or obese subjects.
European journal of clinical investigation 1996;26(10):940-3.
1996: AQ Galvan; Andrea Natali; Simona Baldi; Silvia Frascerra; T Sampietro; Fabio Galetta; Giuseppe Seghieri; Ele Ferrannini
Effect of a reduced-fat diet with or without pravastatin on glucose tolerance and insulin sensitivity in patients with primary hypercholesterolemia.
Journal of cardiovascular pharmacology 1996;28(4):595-602.
1996: C Ambrogi; G Cardini; Simona Baldi; C C Cini; G Buzzigoli; A Quinones-Galvan; Ele Ferrannini
Delta-aminolevulinic acid dehydratase and zinc protoporphyrin in very low lead-exposed pets: a community study.
Veterinary and human toxicology 1996;38(5):336-9.
1996: Elza Muscelli; Andrea Natali; S Bianchi; Roberto Bigazzi; AQ Galvan; Anna Maria Sironi; Silvia Frascerra; Demetrio Ciociaro; Ele Ferrannini
Effect of insulin on renal sodium and uric acid handling in essential hypertension.
American journal of hypertension 1996;9(8):746-52.
1996: AQ Galvan; Elza Muscelli; C Catalano; Andrea Natali; G Sanna; Antonio Masoni; B Bernardini; R Barsacchi; Ele Ferrannini
Insulin decreases circulating vitamin E levels in humans.
Metabolism: clinical and experimental 1996;45(8):998-1003.
1996: Andrea Natali; Alfredo Quiñones-Galvan; F Arzilli; Stefano Taddei; N Pecori; Silvia Frascerra; Antonio Salvetti; Ele Ferrannini
Renovascular hypertension and insulin sensitivity.
European journal of clinical investigation 1996;26(7):556-63.
1996: Riccardo C Bonadonna; Stefano Del Prato; Enzo Bonora; M P Saccomani; G Gulli; Andrea Natali; Silvia Frascerra; N Pecori; Ele Ferrannini; D Bier; C Cobelli; Ralph DeFronzo
Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM.
Diabetes 1996;45(7):915-25.
1996: A Quiønones Galvan; Andrea Natali; Elza Muscelli; Demetrio Ciociaro; N Pecori; Paolo G Camici; Ele Ferrannini
Insulin sensitivity in cardiological syndrome X.
Journal of internal medicine 1996;239(3):241-7.
1996: Ele Ferrannini; Elza Muscelli; Michael P Stern; Steven M Haffner
Differential impact of insulin and obesity on cardiovascular risk factors in non-diabetic subjects.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1996;20(1):7-14.
1995: Stefano Taddei; Agostino Virdis; Paola Mattei; Andrea Natali; Ele Ferrannini; Antonio Salvetti
Effect of insulin on acetylcholine-induced vasodilation in normotensive subjects and patients with essential hypertension.
Circulation 1995;92(10):2911-8.
1995: S Bianchi; Roberto Bigazzi; Alfredo Quiñones-Galvan; Elza Muscelli; G Baldari; N Pecori; Demetrio Ciociaro; Ele Ferrannini; Andrea Natali
Insulin resistance in microalbuminuric hypertension. Sites and mechanisms.
Hypertension 1995;26(5):789-95.
1995: Ele Ferrannini
Physiological and metabolic consequences of obesity.
Metabolism: clinical and experimental 1995;44(9 Suppl 3):15-7.
1995: Alfredo Quiñones-Galvan; Andrea Natali; Simona Baldi; Silvia Frascerra; G Sanna; Demetrio Ciociaro; Ele Ferrannini
Effect of insulin on uric acid excretion in humans.
The American journal of physiology 1995;268(1 Pt 1):E1-5.
1994: Andrea Natali; Riccardo C Bonadonna; D Santoro; AQ Galvan; Simona Baldi; Silvia Frascerra; C Palombo; Sergio Ghione; Ele Ferrannini
Insulin resistance and vasodilation in essential hypertension. Studies with adenosine.
The Journal of clinical investigation 1994;94(4):1570-6.
1994: S Bianchi; Roberto Bigazzi; C Valtriani; I Chiapponi; G Sgherri; G Baldari; Andrea Natali; Ele Ferrannini; Vito M Campese
Elevated serum insulin levels in patients with essential hypertension and microalbuminuria.
Hypertension 1994;23(6 Pt 1):681-7.
1994: Eugene J Barrett; S Bevilacqua; Ralph DeFronzo; Ele Ferrannini
Glycogen turnover during refeeding in the postabsorptive dog: implications for the estimation of glycogen formation using tracer methods.
Metabolism: clinical and experimental 1994;43(3):285-92.
1994: W Yin; Giuseppe Seghieri; C Boni; G Sanna; Roberto Anichini; G Bartolomei; Ele Ferrannini
Effect of chronic ACE inhibition on glucose tolerance and insulin sensitivity in hypertensive type 2 diabetic patients.
Chinese medical sciences journal = Chung-kuo i hsüeh k'o hsüeh tsa chih / Chinese Academy of Medical Sciences 1994;9(1):29-33.
1994: Ele Ferrannini; Giuseppe Seghieri; Elza Muscelli
Insulin and the renin-angiotensin-aldosterone system: influence of ACE inhibition.
Journal of cardiovascular pharmacology 1994;24 Suppl 3():S61-9.
1993: M C Breschi; Giuseppe Seghieri; G Bartolomei; A Gironi; S Baldi; Ele Ferrannini
Relation of birthweight to maternal plasma glucose and insulin concentrations during normal pregnancy.
Diabetologia 1993;36(12):1315-21.
1993: L S Brandi; D Santoro; Andrea Natali; altomonte fiorella; Simona Baldi; Silvia Frascerra; Ele Ferrannini
Insulin resistance of stress: sites and mechanisms.
Clinical science (London, England : 1979) 1993;85(5):525-35.
1993: AQ Galvan; D Santoro; Andrea Natali; T Sampietro; C Boni; Antonio Masoni; G Buzzigoli; Ele Ferrannini
Insulin sensitivity in familial hypercholesterolemia.
Metabolism: clinical and experimental 1993;42(10):1359-64.
1993: Andrea Natali; Alfredo Quiñones-Galvan; D Santoro; N Pecori; Stefano Taddei; Antonio Salvetti; Ele Ferrannini
Relationship between insulin release, antinatriuresis and hypokalaemia after glucose ingestion in normal and hypertensive man.
Clinical science (London, England : 1979) 1993;85(3):327-35.
1993: Ele Ferrannini; Andrea Natali; LS Brandi; Riccardo C Bonadonna; S V De Kreutzemberg; S DelPrato; D Santoro
Metabolic and thermogenic effects of lactate infusion in humans.
The American journal of physiology 1993;265(3 Pt 1):E504-12.
1993: Riccardo C Bonadonna; Stefano Del Prato; M P Saccomani; Enzo Bonora; G Gulli; Ele Ferrannini; D Bier; C Cobelli; Ralph DeFronzo
Transmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetes.
The Journal of clinical investigation 1993;92(1):486-94.
1993: Giuseppe Paolisso; Ele Ferrannini; A D'Amore; C Volpe; Michele Varricchio; F D'Onofrio
Effects of physiological plasma insulin levels on glucose turnover parameters in familial hypercholesterolemia.
Atherosclerosis 1993;101(1):111-5.
1993: Andrea Natali; D Santoro; LS Brandi; D Faraggiana; Demetrio Ciociaro; N Pecori; G Buzzigoli; Ele Ferrannini
Effects of acute hypercarnitinemia during increased fatty substrate oxidation in man.
Metabolism: clinical and experimental 1993;42(5):594-600.
1993: D Santoro; AQ Galvan; Andrea Natali; Ele Ferrannini
Some metabolic aspects of essential hypertension and its treatment.
The American journal of medicine 1993;94(4A):32S-39S.
1993: Ele Ferrannini; D Santoro; Riccardo C Bonadonna; Andrea Natali; O Parodi; Paolo G Camici
Metabolic and hemodynamic effects of insulin on human hearts.
The American journal of physiology 1993;264(2 Pt 1):E308-15.
1993: Riccardo C Bonadonna; M P Saccomani; L Seely; K S Zych; Ele Ferrannini; C Cobelli; Ralph DeFronzo
Glucose transport in human skeletal muscle. The in vivo response to insulin.
Diabetes 1993;42(1):191-8.
1992: Giuseppe Paolisso; Ele Ferrannini; S Sgambato; Michele Varricchio; F D'Onofrio
Hyperinsulinemia in patients with hypercholesterolemia.
The Journal of clinical endocrinology and metabolism 1992;75(6):1409-12.
1992: Ele Ferrannini
The haemodynamics of obesity: a theoretical analysis.
Journal of hypertension 1992;10(11):1417-23.
1992: Giuseppe Seghieri; W Yin; C Boni; G Sanna; Roberto Anichini; G Bartolomei; Ele Ferrannini
Effect of chronic ACE inhibition on glucose tolerance and insulin sensitivity in hypertensive type 2 diabetic patients.
Diabetic medicine : a journal of the British Diabetic Association 1992;9(8):732-8.
1992: LS Brandi; M Grana; T Mazzanti; Francesco Giunta; Andrea Natali; Ele Ferrannini
Energy expenditure and gas exchange measurements in postoperative patients: thermodilution versus indirect calorimetry.
Critical care medicine 1992;20(9):1273-83.
1992: D Santoro; Andrea Natali; Carlo Palombo; L S Brandi; M Piatti; Sergio Ghione; Ele Ferrannini
Effects of chronic angiotensin converting enzyme inhibition on glucose tolerance and insulin sensitivity in essential hypertension.
Hypertension 1992;20(2):181-91.
1992: Ele Ferrannini; AQ Galvan; D Santoro; Andrea Natali
Potassium as a link between insulin and the renin-angiotensin-aldosterone system.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1992;10(1):S5-10.
1991: D Santoro; Andrea Natali; AQ Galvan; Antonio Masoni; P Gazzetti; Ele Ferrannini
Glucose tolerance and insulin secretion in essential hypertension after treatment with an angiotensin converting enzyme inhibitor.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1991;9(6):S406-7.
1991: Paolo G Camici; Paolo Marraccini; Roberto Lorenzoni; G Buzzigoli; N Pecori; A Perissinotto; Ele Ferrannini; Antonio L'Abbate; Mario Marzilli
Coronary hemodynamics and myocardial metabolism in patients with syndrome X: response to pacing stress.
Journal of the American College of Cardiology 1991;17(7):1461-70.
1991: P Camici; Paolo Marraccini; Roberto Lorenzoni; Ele Ferrannini; G Buzzigoli; Mario Marzilli; Antonio L'Abbate
Metabolic markers of stress-induced myocardial ischemia.
Circulation 1991;83(5 Suppl):III8-13.
1991: Andrea Natali; D Santoro; Carlo Palombo; M Cerri; Sergio Ghione; Ele Ferrannini
Impaired insulin action on skeletal muscle metabolism in essential hypertension.
Hypertension 1991;17(2):170-8.
1991: Leif C Groop; Carola Saloranta; M Shank; Riccardo C Bonadonna; Ele Ferrannini; Ralph DeFronzo
The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus.
The Journal of clinical endocrinology and metabolism 1991;72(1):96-107.
1990: Ele Ferrannini; Steven M Haffner; Michael P Stern
Insulin sensitivity and hypertension.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1990;8(7):S169-74.
1990: LS Brandi; M Frediani; M Oleggini; F Mosca; M Cerri; C Boni; N Pecori; G Buzzigoli; Ele Ferrannini
Insulin resistance after surgery: normalization by insulin treatment.
Clinical science (London, England : 1979) 1990;79(5):443-50.
1990: Ele Ferrannini; L D Katz; M G Glickman; Ralph DeFronzo
Influence of combined intravenous and oral glucose administration on splanchnic glucose uptake in man.
Clinical physiology (Oxford, England) 1990;10(6):527-38.
1990: Ele Ferrannini; A Lanfranchi; F Rohner-Jeanrenaud; G Manfredini; GERALD VAN DE WERVE
Influence of long-term diabetes on liver glycogen metabolism in the rat.
Metabolism: clinical and experimental 1990;39(10):1082-8.
1990: G Buzzigoli; L Lanzone; Demetrio Ciociaro; Silvia Frascerra; M Cerri; A Scandroglio; R Coldani; Ele Ferrannini
Characterization of a reversed-phase high-performance liquid chromatographic system for the determination of blood amino acids.
Journal of chromatography 1990;507():85-93.
1990: Andrea Natali; G Buzzigoli; Stefano Taddei; D Santoro; M Cerri; R Pedrinelli; Ele Ferrannini
Effects of insulin on hemodynamics and metabolism in human forearm.
Diabetes 1990;39(4):490-500.
1990: S Bevilacqua; G Buzzigoli; Riccardo C Bonadonna; LS Brandi; M Oleggini; C Boni; M Geloni; Ele Ferrannini
Operation of Randle's cycle in patients with NIDDM.
Diabetes 1990;39(3):383-9.
1990: Ele Ferrannini; Steven M Haffner; Michael P Stern
Essential hypertension: an insulin-resistant state.
Journal of cardiovascular pharmacology 1990;15 Suppl 5():S18-25.
1989: C Cobelli; M P Saccomani; Ele Ferrannini; Ralph DeFronzo; R Gelfand; Riccardo C Bonadonna
A compartmental model to quantitate in vivo glucose transport in the human forearm.
The American journal of physiology 1989;257(6 Pt 1):E943-58.
1989: Ele Ferrannini; L C Groop
Hepatic glucose production in insulin-resistant states.
Diabetes/metabolism reviews 1989;5(8):711-26.
1989: P Camici; Ele Ferrannini; Lionel Henry Opie
Myocardial metabolism in ischemic heart disease: basic principles and application to imaging by positron emission tomography.
Progress in cardiovascular diseases 1989;32(3):217-38.
1989: Riccardo C Bonadonna; K Zych; C Boni; Ele Ferrannini; Ralph DeFronzo
Time dependence of the interaction between lipid and glucose in humans.
The American journal of physiology 1989;257(1 Pt 1):E49-56.
1989: Leif C Groop; Riccardo C Bonadonna; S DelPrato; K Ratheiser; K Zyck; Ele Ferrannini; Ralph DeFronzo
Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance.
The Journal of clinical investigation 1989;84(1):205-13.
1989: Ele Ferrannini; L Locatelli; E Jequier; J P Felber
Differential effects of insulin and hyperglycemia on intracellular glucose disposition in humans.
Metabolism: clinical and experimental 1989;38(5):459-65.
1989: Ralph DeFronzo; Ele Ferrannini; D C Simonson
Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake.
Metabolism: clinical and experimental 1989;38(4):387-95.
1989: Ele Ferrannini; Andrea Natali; M Cerri; D Santoro; Carlo Palombo
Hypertension: a metabolic disorder?
Diabète & métabolisme 1989;15(5 Pt 2):284-91.
1988: Ele Ferrannini; G Buzzigoli; S Bevilacqua; C Boni; D Del Chiaro; M Oleggini; LS Brandi; F Maccari
Interaction of carnitine with insulin-stimulated glucose metabolism in humans.
The American journal of physiology 1988;255(6 Pt 1):E946-52.
1988: Ele Ferrannini; Stefano Taddei; D Santoro; Andrea Natali; C Boni; D Del Chiaro; G Buzzigoli
Independent stimulation of glucose metabolism and Na+-K+ exchange by insulin in the human forearm.
The American journal of physiology 1988;255(6 Pt 1):E953-8.
1988: Livio Luzi; Eugene J Barrett; L C Groop; Ele Ferrannini; Ralph DeFronzo
Metabolic effects of low-dose insulin therapy on glucose metabolism in diabetic ketoacidosis.
Diabetes 1988;37(11):1470-7.
1988: Alain Golay; Ralph DeFronzo; Ele Ferrannini; D C Simonson; D Thorin; K Acheson; D Thiébaud; B Curchod; Eric Jéquier; J P Felber
Oxidative and non-oxidative glucose metabolism in non-obese type 2 (non-insulin-dependent) diabetic patients.
Diabetologia 1988;31(8):585-91.
1988: LS Brandi; M Oleggini; M Frediani; S Lachi; M Di Trani; Ele Ferrannini
Inadvertent catheterization of the internal thoracic vein mimicking pulmonary embolism: a case report.
JPEN. Journal of parenteral and enteral nutrition 1988;12(2):221-2.
1988: Ele Ferrannini; Ralph DeFronzo; Richard J Gusberg; J Tepler; Ralph Jacob; M Aaron; D Smith; Eugene J Barrett
Splanchnic amino acid and glucose metabolism during amino acid infusion in dogs.
Diabetes 1988;37(2):237-45.
1988: LS Brandi; M Oleggini; S Lachi; M Frediani; S Bevilacqua; F Mosca; Ele Ferrannini
Energy metabolism of surgical patients in the early postoperative period: a reappraisal.
Critical care medicine 1988;16(1):18-22.
1988: Ele Ferrannini; D C Simonson; Lee D Katz; G Reichard; S Bevilacqua; Eugene J Barrett; M Olsson; Ralph DeFronzo
The disposal of an oral glucose load in patients with non-insulin-dependent diabetes.
Metabolism: clinical and experimental 1988;37(1):79-85.
1988: J P Felber; Alain Golay; Eric Jéquier; B Curchod; E Temler; Ralph DeFronzo; Ele Ferrannini
The metabolic consequences of long-term human obesity.
International journal of obesity 1988;12(5):377-89.
1987: D Smith; L Rossetti; Ele Ferrannini; C M Johnson; C Cobelli; G Toffolo; Lee D Katz; Ralph DeFronzo
In vivo glucose metabolism in the awake rat: tracer and insulin clamp studies.
Metabolism: clinical and experimental 1987;36(12):1167-74.
1987: J P Felber; Ele Ferrannini; A Golay; H U Meyer; D Theibaud; B Curchod; E Maeder; E Jequier; Ralph DeFronzo
Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes.
Diabetes 1987;36(11):1341-50.
1987: S Bevilacqua; Riccardo C Bonadonna; G Buzzigoli; C Boni; Demetrio Ciociaro; F Maccari; M A Giorico; Ele Ferrannini
Acute elevation of free fatty acid levels leads to hepatic insulin resistance in obese subjects.
Metabolism: clinical and experimental 1987;36(5):502-6.
1986: Ele Ferrannini; Eugene J Barrett; S Bevilacqua; R Jacob; M Walesky; Robert S Sherwin; Ralph DeFronzo
Effect of free fatty acids on blood amino acid levels in human.
The American journal of physiology 1986;250(6 Pt 1):E686-94.
1985: S Bevilacqua; Eugene J Barrett; D Smith; D C Simonson; M Olsson; P Bratusch-Marrain; Ele Ferrannini; Ralph DeFronzo
Hepatic and peripheral insulin resistance following streptozotocin-induced insulin deficiency in the dog.
Metabolism: clinical and experimental 1985;34(9):817-25.
1985: Eugene J Barrett; Ele Ferrannini; R Gusberg; S Bevilacqua; Ralph DeFronzo
Hepatic and extrahepatic splanchnic glucose metabolism in the postabsorptive and glucose fed dog.
Metabolism: clinical and experimental 1985;34(5):410-20.
1984: D C Simonson; Ele Ferrannini; S Bevilacqua; D Smith; E Barrett; R Carlson; Ralph DeFronzo
Mechanism of improvement in glucose metabolism after chronic glyburide therapy.
Diabetes 1984;33(9):838-45.
1983: Ele Ferrannini; Eugene J Barrett; S Bevilacqua; Ralph DeFronzo
Effect of fatty acids on glucose production and utilization in man.
The Journal of clinical investigation 1983;72(5):1737-47.
1982: Eugene J Barrett; Ralph DeFronzo; S Bevilacqua; Ele Ferrannini
Insulin resistance in diabetic ketoacidosis.
Diabetes 1982;31(10):923-8.
1982: Ele Ferrannini; E Barrett; S Bevilacqua; J Dupre; Ralph DeFronzo
Sodium elevates the plasma glucose response to glucose ingestion in man.
The Journal of clinical endocrinology and metabolism 1982;54(2):455-8.
1981: S Bevilacqua; E Barrett; Ele Ferrannini; R Gusberg; A Stewart; L Richardson; D Smith; Ralph DeFronzo
Lack of effect of parathyroid hormone on hepatic glucose metabolism in the dog.
Metabolism: clinical and experimental 1981;30(5):469-75.